Introduction {#s1}
============

Many parasites switch between multiple hosts in order to complete their life cycles. These host switches are often accompanied by population bottlenecks where just a few parasites are sufficient for infection. For *Plasmodium*, the causative agent of malaria, a host switch is followed by an expansion of the parasite population in both the insect and the vertebrate host. A single *Plasmodium* parasite that establishes itself in the mosquito gut is enough to form an extracellular oocyst, in which hundreds of sporozoites can develop to colonize the salivary gland and be injected back into the vertebrate host. In *Plasmodium* species that infect mammals, a single sporozoite that successfully enters a hepatocyte is enough to produce thousands of progeny red-blood-cell-invading merozoites that then cause a full infection. In order to progress to the next developmental stage, the fully formed parasites need to escape their respective host cell or the oocyst.

These different immediate environments --- a red blood cell within the blood stream, a hepatocyte within the liver parenchyma and an oocyst underneath the basal lamina of the mosquito gut --- suggest that the different parasite stages use a mixture of unique and conserved processes for egress. There is evidence from all three stages to show that the release of parasites is dependent on a common set of specific proteins encoded by the parasite, including different proteases especially of the SERA family ([@bib4]; [@bib56]) but also other factors with no or unknown enzymatic activity ([@bib56]; [@bib76]; [@bib65]; [@bib53]; [@bib15]; [@bib34]). Egress from blood cells and hepatocytes has been filmed in spectacular detail ([@bib1]; [@bib62]), and exflagellation of microgametes has been studied extensively by light and electron microscopy ([@bib58]; [@bib18]; [@bib75]; [@bib74]). These movies show, for example, the rapid rupture of the red blood cell membrane upon release of merozoites ([@bib1]), as well as the perforation of the parasitophorous vacuolar membrane (PVM) and the erythrocyte membrane to enable exflagellation of activated male gametocytes ([@bib58]; [@bib18]; [@bib75]). Finally, intravital microscopy in mice revealed the formation of merozoite-containing vesicles, termed merosomes, that bud from the infected hepatocyte ([@bib62]; [@bib6]). By contrast, we have no live visual information about sporozoite egress from oocysts. Indeed, despite the adaptation of new dynamic imaging approaches in parasite biology ([@bib25]; [@bib16]; [@bib3]), the only evidence to show how sporozoites egress from oocysts are images from electron microscopy. These show that sporozoites can appear in holes within the oocyst wall and the basal lamina that surrounds the oocysts ([@bib61]; [@bib45]; [@bib59]), but also suggest that oocysts could rupture to release many parasites simultaneoulsly ([@bib45]). Different species might use or prefer different ways to egress ([@bib50]).

A number of proteins have been identified as essential for sporozoite egress from oocysts of the human malaria parasite *P. falciparum* and of the rodent model malaria parasite *P. berghei* ([Table 1](#tbl1){ref-type="table"}). Some of the parasite lines that lack these proteins cannot exit the oocysts but can still migrate when mechanically released from oocysts whereas others cannot. Curiously, parasites lacking the thrombospondin-related anonymous protein (TRAP) also fail to undergo productive motility and salivary gland invasion, yet they have no defect in egress from oocysts ([@bib63]; [@bib49]). Nevertheless, sporozoites that lack TRAP are still able to perform forms of unproductive movement, during which the parasite is attached at one focal spot to the substrate ([@bib49]), which might be sufficient to force egress from oocysts. However, the number of non-related proteins that function in egress, and the lack of any clear interaction between these proteins, suggests that even more proteins are involved in the egress of sporozoites from oocysts. It was recently shown that the TRAP-family member MTRAP, previously thought to be important for red blood cell invasion by merozoites, is crucial for the egress of gametocytes from host cells ([@bib37]; [@bib8]). We rationalized that similar proteins might also play a role in oocyst egress and searched for distantly related TRAP-like proteins. This revealed an as yet uncharacterized protein that carries a single thrombospondin repeat, one of the two adhesive domains found in TRAP-family members. This thrombospondin-related protein 1, TRP1, also shared a transmembrane domain and a similar cytoplasmic tail with TRAP-family proteins ([Figure 1](#fig1){ref-type="fig"}). The generation of TRP1-deficient parasites revealed a function for TRP1 in sporozoite egress from oocysts. Upon filming sporozoite egress from oocysts in isolated midguts, we found that motility precedes egress and that sporozoites that lack TRP1 are not motile within oocysts. Intriguingly, isolated *trp1(-)* sporozoites can undergo motility, suggesting that TRP1 might play a role in activating sporozoite motility in vivo prior to egress from oocysts.10.7554/eLife.19157.003Figure 1.The thrombospondin-related protein 1 (TRP1) shares distinct domains with TRAP-family proteins, belongs to the family of TRAP-like proteins and is present in all *Plasmodium* species.(**A**) TSR-containing proteins in *Plasmodium*. TRAP-family proteins are marked with a red bar, whereas TRAP-related proteins are indicated by a green bar and other TSR-containing proteins by a blue bar. TRP1 is encircled by a dashed line (top right). Thrombospondin repeats are shown as blue boxes (labeled with T) and Von Willebrandt factor like A-domains are depicted as red hexagons (labeled with A). Signal peptides are shown as black boxes and transmembrane domains as light green ovals. CSP possesses a GPI-anchor (grey triangle), whereas SPATR harbors an EGF-domain (white box). Conserved tryptophans are indicated with a W. Protein schemes are not drawn to scale and amino acid numbers refer to *P. berghei* proteins. (**B**) Protein model of *Pb*TRP1 (PBANKA_0707900; 896 amino acids) in comparison to *Pb*TRAP (PBANKA_1349800, 606 amino acids, not to scale). Both proteins contain a signal peptide (SP), a thrombospondin type-I repeat (TSR), a transmembrane domain (TMD) and a cytoplasmic tail domain (CTD), but TRP1 lacks the conserved tryptophan (W) that is typically found at the C-terminus of TRAP-family proteins. Instead of the Von Willebrandt factor-like A-domain in TRAP, TRP1 contains a long N-terminal extension. (**C**) Multiple sequence alignment of the *Pb*TRP1 TSR with TSRs from the TRAP-family (*Pb*TRAP, *Tg*MIC2, *Pb*CTRP, *Pb*S6 and *Pb*TLP) and other TSR-containing proteins (*Pb*TRAMP and *Pb*CSP). (**D**) Length (in amino acids) and isoelectric point (pI) of the CTDs of TRP1 and TRAP from different *Plasmodium* species.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.003](10.7554/eLife.19157.003)10.7554/eLife.19157.004Table 1.Summary of known gene deletions and genetic modifications associated with defects in sporozoite egress from oocysts.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.004](10.7554/eLife.19157.004)**StrainEgress from oocystsIn vitro motilitySalivary gland invasionRecognizable domain / function*wt*+++++++++/*sera5(-*)\*-+++-protease*csp-RIImut***^27^**-n.a**.**n.a**.**thrombospondin repeat (TSR)*csp(RI^−^)***^57^**n.a**.**+++++TSR*csp(RII^−^)***^57^**n.a**.**-+TSR*ccp2(-)* and *ccp3(-)*-++n.a**.**LCCL-like, ricin, discoidin, ApicA, levanase and neurexin-like domains*pcrmp3(-)* and *pcrmp4(-)*-+++n.a**.**CRM domain, EGF-like domain*gama(-)^†^*--n.a**.**/*siap-1(-)*+-+/*orp1(-)^‡^*-+++-histon-fold domain (HFD)*orp2(-)^‡^*-+++-HFD*trp1(-)*-+++-TSR**[^1][^2][^3]

Results {#s2}
=======

TRP1 belongs to the family of TRAP-related proteins {#s2-1}
---------------------------------------------------

Within the mosquito, *Plasmodium* sporozoites display a repertoire of proteins that are important for egress from oocysts (SERA5, CSP, GAMA, SIAP-1, PCRMP3 and 4, and CCp2 and 3), motility (e.g. TRAP, MAEBL and S6) and salivary gland entry (e.g. TRAP and MAEBL). CSP in particular is interesting as it is essential for sporozoite formation ([@bib48]), as well as for efficient egress from oocysts once sporozoites have formed ([@bib73]; [@bib13]) and also for sporozoite invasion of the salivary glands ([@bib13]). While the structure of CSP\'s N-terminus is unknown, the α-thrombospondin repeat (αTSR) at the C-terminal end as well as the repeat region between the N- and the C-terminus have been solved by x-ray crystallography and NMR ([@bib21]; [@bib52]; [@bib27]). The αTSR is especially interesting because this domain is believed to be involved in protein-protein interactions, as shown for the TSRs of thrombospondin-1 ([@bib33]). Proteins containing TSRs are widespread among animals and protozoans and are mostly extracellular or secreted proteins ([@bib69]). Also, at least one TSR is contained within all proteins of the TRAP-family, including MTRAP, which was recently found to be important for gametocyte egress from red blood cells ([@bib37]; [@bib8]; [@bib47]) ([Figure 1A](#fig1){ref-type="fig"}). In a search for uncharacterized TRAP-family-like TSR-containing proteins, we found a protein with unknown function in the rodent model parasite *P. berghei* (PBANKA_0707900). Because of the presence of a single TSR as a sole detectable domain, we will refer to this protein as thrombospondin-related protein 1 (TRP1).

The general domain composition of TRP1 shows many similarities to that of the thrombospondin-related anonymous protein (TRAP) ([@bib63]; [@bib47]) ([Figure 1B](#fig1){ref-type="fig"}). The *TRP1* gene is intron-less, resides on chromosome 7 and encodes 896 amino acids. It can be found in all *Plasmodium* species and has a highly conserved core region that includes the TSR and the TMD (Figure 5A, [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). Both TRP1 and TRAP contain a signal peptide (SP), a TSR, a transmembrane domain (TMD) and a cytoplasmic tail domain (CTD) ([Figure 1B](#fig1){ref-type="fig"}). However, TRP1 lacks the penultimate tryptophan (W) that has been shown to be important for TRAP function ([@bib36]) as well as the von Willebrandt factor like A-domain that is present at the N-terminus of TRAP and important for invasion ([@bib44]). Nevertheless, not all of the TRAP-family proteins --- CTRP, S6/TREP/UOS3, TLP and MTRAP --- possess an A-domain, but they are unified by the conserved C-terminal tryptophan residue ([@bib47]). In comparison to that of TRAP, the N-terminal domain of TRP1 is less conserved and varies widely in length between different *Plasmodium* species (332 aa in *P. vivax*; 651 aa in *P. falciparum*) ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). A similar observation was made for the CTD. Whereas the CTD domain of TRP1 contains 19 amino acids in *P. falciparum*, it has a length of 97 amino acids in *P. knowlesi*. By contrast, the TSR of TRP1 is well conserved but has an unusual long insertion of 10 amino acids when compared to TSRs from other apicomplexan proteins ([Figure 1C](#fig1){ref-type="fig"}). Clusters of acidic amino acids at the C-terminus have been shown to be important for TRAP function ([@bib36]). However, the calculated isoelectric point (pI) of the CTD of TRP1 varied widely between homologues from different *Plasmodium* species and indicated no enrichment for acidic amino acids ([Figure 1D](#fig1){ref-type="fig"}). Due to the overall similarity to TRAP-family proteins, we grouped TRP1 together with TRAMP ([@bib68]; [@bib57]), TRSP ([@bib41]) and SSP3 ([@bib29]) in the family of TRAP-related proteins that have a potential cytoplasmic tail domain (CTD) but lack the conserved tryptophan ([Figure 1A](#fig1){ref-type="fig"}). Homologues of TRP1 can be found in all *Plasmodium* species, but we could not identify homologues in other apicomplexans. However, homology predictions are difficult because TRP1 lacks a unique feature that allows unambiguous identification of protein homologues. As many TSR-containing proteins in other apicomplexan parasites are still uncharacterized, we cannot exclude the possibility that functional homologues exist outside of the genus *Plasmodium*.

Oocysts lacking TRP1 develop normally but sporozoites fail to egress {#s2-2}
--------------------------------------------------------------------

To study the function of TRP1, we created the knockout lines *trp1(-)* and *trp1(-)mCh* ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). *trp1(-)* is non-fluorescent, whereas in the *trp1(-)mCh* line, the *trp1* gene is replaced by the gene encoding the fluorescent protein mCherry. Expression of mCherry in *trp1(-)mCh* parasites was only observed in budding and completely sporulated oocysts up to hemolymph sporozoites ([Figure 2A](#fig2){ref-type="fig"}). To see if the lack of *trp1* affects the development of oocysts, we counted the number of oocysts at different time points after infection of mosquitoes by *trp1(-)mCh* or the fluorescent control line *fluo* ([@bib40]), which expresses mCherry under control of the *CSP* promoter and GFP under control of the *ef1α* promoter ([Figure 2B](#fig2){ref-type="fig"}). Oocyst numbers for the control decreased between day 12 and day 22, whereas the number of oocysts in infected *trp1(-)mCh* mosquitoes remained stable. To screen for morphological differences between *trp1(-)mCh* and the control line, oocysts at day 12 and day 22 were also imaged and classified into oocysts containing mature or budding sporozoites (sporulated) and oocysts that didn't contain any sporozoite structures (unsporulated) ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). This imaging showed that the percentage of *trp1(-)mCh* oocysts that had undergone or started sporogony (sporulated) was higher than the number of pre-mature (unsporulated) oocysts at both day 12 and day 22. While there was only a slight difference in this ratio between control and knockout on day 12, over 80% of the *trp1(-)mCh* oocysts were sporulated on day 22 compared with just 45% in the control line. As no morphological difference between sporulated knockout and control oocysts could be observed ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), we assumed that *trp1(-)mCh* sporozoites are fully developed but not able to egress. To study the infectivity of sporozoites lacking TRP1, we performed transmission experiments using either bites by infected mosquitoes or intravenous injections of 400,000--500,000 midgut sporozoites (Table 3, [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}, Figure 4---figure supplement 2). These experiments showed that mosquitoes infected with both knockout lines could not transmit the parasites to mice. However, we observed no difference in prepatencies between wild-type and *trp1(-)* parasites if midgut sporozoites were injected intravenously.10.7554/eLife.19157.005Figure 2.*trp1(-)* oocysts sporulate normally and persist in a sporulated state.(**A**) Expression of mCherry in *trp1(-)mCh* parasites was only observed in sporulating oocysts and sporozoites. The developmental stage of the oocysts is depicted schematically above the images, while the increase in fluorescence intensity is schematically indicated below. Strong mCherry expression was only observed in budding or mature oocysts. Scale bar: 10 µm. (**B**) Oocyst numbers of infected midguts for *trp1(-)mCh* and wild-type parasites at day 12 and day 22 post-infection. \* depicts p\<0.05; one-way ANOVA followed by a Kruskal-Wallis test. Horizontal bars indicate the median. Data were generated from two (*trp1(-)mCh*) and three (*fluo*) different feeding experiments, respectively. (**C**) Percentages of sporulated and unsporulated oocysts in *trp1(-)mCh* and wild-type infected midguts at 12 and 22 days post infection. \* depicts p\<0.05; one-tailed Student\'s t-test. The mean and the SEM are shown. Data were generated from three different feeding experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.005](10.7554/eLife.19157.005)10.7554/eLife.19157.006Figure 2---figure supplement 1.Generation and PCR analysis of *trp1(-), trp1(-)mCh* and *trp1(-)rec* parasites.(**A**) Schematic representation of the strategy for gene deletion and marker recycling via negative selection. Two different *trp1(-)* lines were generated by independent transfection of two different constructs into wild-type (*wt) P. berghei* strain ANKA parasites. The vector contained the positive-negative selection marker *hdhfr-yfcu*. The marker gene was flanked by \~1 kb sequences upstream and downstream of the open reading frame of *trp1* to generate a knockout line by double crossover homologous recombination (*trp1(-))*. In addition, a second vector was generated to visualize *trp1* promoter activity in vivo via expression of mCherry (*trp1(-)mCh*). Location of primers and the approximate length of the PCR fragments used for genotyping are indicated by arrows and lines below the scheme. (**B**) PCR analysis of clonal *trp1(-)* and *trp1(-)mCh* parasites. Note the shift in size of the complete locus (full) between *trp1(-)mCh* and *wt*. The expected sizes of the PCR products are indicated below. PCR analysis of negatively selected knockout parasites *trp1(-)rec* revealed loss of the selection cassette. Note the shift in size of the PCR product for the selection marker (SM) before and after negative selection. (**C**) RT-PCR with cDNA generated from *trp1(-)* and *trp1(-)mCh* midgut sporozoites. The PCR with the primers P1411/P1444 shows the presence of cDNA indicated by the loss of an intron and the shift in size of α-tubulin I. The PCR with the primers P697/P1410 is specific for *trp1*. An internal control with gDNA from the *P. berghei ANKA* strain is also shown to verify that the PCR worked. See also [Figure 5](#fig5){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.006](10.7554/eLife.19157.006)10.7554/eLife.19157.007Figure 2---figure supplement 2.Classification of oocysts as unsporulated or sporulated.Examples of unsporulated and sporulated *trp1(-)mCh* and *wt* oocysts at day 12 and day 22. Note that oocysts with budding sporozoites as well as oocysts with completely developed sporozoites were classified as sporulated. Scale bar: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.007](10.7554/eLife.19157.007)10.7554/eLife.19157.008Figure 2---figure supplement 3.*trp1(-)* and *trp(-)mCh* midgut sporozoites are infective to mice if intravenously injected.(**A**) Midgut sporozoites of *trp1(-)* (400,000), *wt* (500,000) and *trp1(-)mCh* (500,000) were injected intravenously into four mice each. Parasitemia was monitored for 10 days post infection. Shown are the mean and SEM of four (*trp1(-)mCh*), two (*trp1(-)*) and three (*wt*) mice, which became blood-stage patent. (**B**) Parasitemia at day 9 post infection of the *wt*- and *trp1(-)mCh-*infected mice represented in (**A**).**DOI:** [http://dx.doi.org/10.7554/eLife.19157.008](10.7554/eLife.19157.008)

TRP1-knockout parasites are impaired in oocyst egress and salivary gland invasion but show no defect in motility {#s2-3}
----------------------------------------------------------------------------------------------------------------

Given the block in transmission by mosquitoes infected with the *trp1(-)* or *trp1(-)mCh* knockout parasites, we investigated the number of sporozoites in the midgut, hemolymph and salivary glands over time. In mosquitoes infected with wild-type parasites, midgut sporozoites start to egress from oocysts 11--12 days post infection; hence their numbers in the midgut decrease over time, while the numbers of hemolymph and salivary gland sporozoites slowly increase ([Figure 3A](#fig3){ref-type="fig"}). By contrast, mosquitoes that are infected with *trp1(-)* or *trp1(-)mCh* consistently showed high numbers of midgut sporozoites until 22 days post infection, while we observed only few sporozoites in the hemolymph and none in salivary glands ([Table 2](#tbl2){ref-type="table"}, [Figure 3A](#fig3){ref-type="fig"}). To visualize this effect more clearly, we calculated the ratio of hemolymph sporozoites (HLS) to midgut sporozoites (MGS) and salivary gland sporozoites (SGS) to MGS. The ratio for SGS to MGS was zero for both *trp1(-)* lines, while the ratio for HLS to MGS was either zero (*trp1(-)*) or very low (*trp1(-)mCh*) ([Figure 3B,C](#fig3){ref-type="fig"}). We also generated two *sera5(-)* strains ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) that were used as control for a non-egressing strain ([@bib2]). Ratios of SGS to MGS and HLS to MGS for both strains gave similar results as for *trp1(-)* and *trp1(-)mCh* ([Figure 3B,C](#fig3){ref-type="fig"}). To investigate the cause of failure to egress, we performed motility assays of wild-type and *trp1(-)mCh* midgut and hemolymph sporozoites. Both wild-type and *trp1(-)* sporozoites derived from midguts were able to perform the typical circular gliding motility of sporozoites ([@bib71]) but at very low rates (ca. 0.5--1% of the population) on day 15 ([Figure 3D](#fig3){ref-type="fig"}). This fraction increased in hemolymph sporozoites to 10--20% of the population, and again, no significant difference between *trp1(-)* and wild-type sporozoites was observed ([Figure 3E,F](#fig3){ref-type="fig"}). Interestingly the fraction of motile midgut sporozoites increased in the *trp1(-)mCh* line over time and reached a level comparable to that of wild-type hemolymph sporozoites at day 22 post infection ([Figure 3D,E](#fig3){ref-type="fig"}). By contrast, we observed no difference in the percentage of moving midgut wild-type sporozoites between day 15 and day 25 ([Figure 3D](#fig3){ref-type="fig"}). 10.7554/eLife.19157.009Figure 3.*trp1(-)* sporozoites are impaired in oocyst egress and salivary gland invasion but show normal gliding motility in vitro.(**A**) Numbers of wild-type, *trp1(-)* and *trp1(-)mCh* sporozoites in midguts, hemolymph and salivary glands over time. Shown are one to three countings per time point from one to three different feeding experiments. (**B**) Ratio of hemolymph (HLS) to midgut (MGS) sporozoites in wild-type-, *trp1(-)-* and *trp1(-)mCh-*infected mosquitoes. As negative control for a parasite that is not able to egress, a fluorescent and a non-fluorescent *sera5(-)* line were used. The bar represents the mean of four independent countings (ten mosquitoes each) at days 14, 17/18, 20 and 22 post infection of a selected feeding experiment. Error bars represent SEM. For absolute numbers see [Table 2](#tbl2){ref-type="table"}. (**C**) Ratio of salivary gland (SGS) to midgut (MGS) sporozoites corresponding to (**B**). The bar represents the mean, and error bars reflect SEM. For absolute numbers see [Table 2](#tbl2){ref-type="table"}. (**D**) Percentage of moving (dark) and non-moving (white) midgut sporozoites of wild-type and *trp1(-)mCh* at the indicated days post infection. Sporozoites were classified as moving if they were able to glide for at least one full circle within five minutes. All sporozoites that behaved differently were classified as non-moving. The number of investigated sporozoites is indicated on top of the bars. (**E**) Percentage of moving (dark) and non-moving (white) hemolymph sporozoites of wild-type and *trp1(-)mCh*. (**F**) Example of a non-moving (floating, left column) and a moving (circular movement, right column) *trp1(-)mCh* sporozoite isolated from the hemolymph. Scale bar: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.009](10.7554/eLife.19157.009)10.7554/eLife.19157.010Figure 3---figure supplement 1.Generation and PCR analysis of *sera5(-) fluo* and *sera(5) non-fluo* parasites.Schematic representation of the *sera5* knockout strategy. (**A**) Two different *sera5(-)* lines were generated by two independent transfections, one into *wt* and one into the fluorescent-selection marker-free line *fluo*. The vector contained the positive-negative selection marker *hdhfr-yfcu*. The marker gene was flanked by \~1 kb sequences upstream and downstream of the open reading frame of *sera5* to generate a knockout line by double crossover homologous recombination. Positive transfections gave rise to two different lines named *sera5(-*) *fluo* and *sera5(-) non-fluo*. The location of primers and the approximate length of PCR fragments used for genotyping are indicated by arrows and lines below the scheme. (**B**) PCR analysis of clonal *sera5(-*) *fluo* and *sera5(-) non-fluo* parasites. The expected sizes of PCR products are indicated below the gel images.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.010](10.7554/eLife.19157.010)10.7554/eLife.19157.011Table 2.Sporozoite numbers in midgut (MG), hemolymph (HL) and salivary glands (SG). Sporozoites were counted at day 14, 17/18, 20 and 22 post infection. The mean and the standard deviation (± SD) of countings from two to three different feeding experiments are shown. Note that not all dissected mosquitoes were infected and hence numbers per infected mosquito are higher.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.011](10.7554/eLife.19157.011)**Parasite lineNo. of MG sporozoites per mosquitoNo. of HL sporozoites per mosquitoMG / HLNo. of SG sporozoites per mosquito*wt***18,100 (±10,600)1,400 (±1,700)137,800 (±5,300)***trp1(-)***42,400 (±12,500)100 (±100)4240***trp1(-)*mCh**101,200 (±46,800)800 (±300)1270***sera5(-)*** ***fluo***35,700 (±11,900)0/0***sera5(-)*** ***non-fluo***50,100 (±12,900)0/25 (±50)***gfp-trp1comp***45,600 (±20,200)3,500 (±2,900)138,900 (±6,800)***gfp-trp1***9,800 (±10,200)1,500 (±2,100)71,900 (±2,000)***gfp-trp1∆N***18,900 (±12,700)1,000 (±700)190***gfp-trp1∆C***52,700 (±9.500)1,100 (±300)480***trp1-gfp*** ***parental***3,400 (±1,600)n.a.n.a.175 (±100)***trp1-gfp*** ***clonal***9,300 (±4,500)2,600 (±1,500)4600 (±750)

Complementation with full-length TRP1 restores infectivity {#s2-4}
----------------------------------------------------------

For the generation of the knockout lines *trp1(-)* and *trp1(-)mCh*, we made use of the positive-negative selection cassette *hdhfr-yfcu* ([@bib10]). This made it possible to recycle the selection marker in *trp1(-)* parasites to generate the marker-free line *trp1(-)rec* ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). We used this line for complementation approaches with full-length as well as N- and C-terminally truncated *trp1* mutants to further investigate the defects in oocyst egress and potential salivary gland invasion. The construct designed for complementation (*gfp-trp1comp*) contained the full-length *trp1* gene, whereas in the N-terminal deletion mutant (*gfp-trp1∆N*), the sequence after the signal peptide until the start of the TSR (549 aa) was removed. On the other hand, the C-terminal deletion mutant (*gfp-trp1∆C*) lacked the last 41 amino acids of the open reading frame, corresponding to the CTD ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). All generated constructs contained an N-terminal GFP placed in-between the signal sequence and the remaining ORF that allowed the visualization of the expression and localization of the fusion proteins. Transfections into *trp1(-)rec* gave rise to the three parasite lines *gfp-trp1comp*, *gfp-trp1∆N* and *gfp-trp1∆C* ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). The full-length construct was additionally transfected into *wt* to generate the line *gfp-trp1*. Both, *gfp-trp1comp* and *gfp-trp1* parasites showed normal ratios of HLS to MGS as well as of SGS to MGS that were comparable to *wt* ([Figure 4A,B](#fig4){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}). The observed sporozoites numbers in midgut, hemolymph and salivary glands between day 18 and day 22 in mosquitoes infected with *gfp-trp1comp* indicate the fully restored capacity to egress and invade ([Figure 4C,D](#fig4){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}).10.7554/eLife.19157.012Figure 4.Complementation of *trp1(-)* parasites with full-length but not truncated TRP1 restores the wild-type phenotype.(**A**) Ratio of hemolymph sporozoites (HLS) to midgut sporozoites (MGS) and (**B**) of salivary gland sporozoites (SGS) to midgut sporozoites (MGS) for *gfp-trp1∆N, gfp-trp1∆C gfp-trp1comp* and *gfp-trp1* lines in comparison to wild-type (*wt*) parasites. The bar charts show the mean of four independent countings (10 mosquitoes each) at days 14, 18, 20 and 22 post infection of a selected feeding experiment. For absolute numbers see [Table 2](#tbl2){ref-type="table"}. Error bars represent SEM. (**C**) Sporozoites of *gfp-trp1comp* in midguts, salivary glands and hemolymph counted over time; 1--2 countings per timepoint. (**D**) Mechanically ruptured salivary gland releasing *gfp-trp1comp* sporozoites. Scale bar: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.012](10.7554/eLife.19157.012)10.7554/eLife.19157.013Figure 4---figure supplement 1.Generation and PCR analysis of *gfp-trp1comp*, *gfp-trp1*, *gfp-trp1∆N* and *gfp-trp1∆C* parasites.Schematic representation of the complementation strategy with sequences encoding full-length and truncated TRP1 proteins. (**A**) Complementation was performed with three different constructs (*gfp-trp1*, *gfp*-*trp1∆N* and *gfp-trp1∆C*). All constructs contained the positive selection marker *hdhfr* under control of the *ef1α* promoter and a *GFP* gene at the N-terminal end, between the sequence encoding the signal peptide and the remaining *trp1* ORF. The location of primers and the length of PCR fragments used for genotyping are indicated by arrows and black lines below the scheme. Approximate sizes of the PCR products are indicated below the images. (**B**) PCR analysis of clonal lines revealed correct integration of the designed constructs. To probe for the absence of deleted sequences, two PCRs specific for the N- and C-terminus of *trp1* (n-term and c-term) were performed. The PCR termed GFP amplifies a sequence between *GFP* and *trp1* to test the fusion of both sequences. For comparison, the PCRs for both recipient lines *trp1(-)rec* and *wt* are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.013](10.7554/eLife.19157.013)10.7554/eLife.19157.014Figure 4---figure supplement 2.TRP1 is essential for transmission by infected mosquitoes.(**A**,**B**) Parasitemia in mice exposed to ten mosquitoes infected (**A**) with *gfp-trp1:comp*, *gfp-trp1∆C* and *gfp-trp1∆N *and (**B**) with *trp1(-), trp1(-)mCh* and *gfp-trp1*. Blood stage parasites were monitored for 10 days post infection. The graphs show the mean and the standard error of the mean (SEM) of the parasitemia for all infected mice per group (n). (**C,D**) The survival of mice infected with *gfp-trp1comp*, *gfp-trp1∆C* and *gfp-trp1∆N* (corresponding to (**A**)) and with *trp1(-), trp1(-)mCh* and *gfp-trp1* (corresponding to (**B**)). The viability of all mice was monitored for 30 days post infection.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.014](10.7554/eLife.19157.014)

Interestingly, we observed higher numbers of hemolymph sporozoites in mosquitoes infected with *gfp-trp1∆N* and *gfp-trp1∆C* than in those infected with the knockout strains. Despite similar numbers of hemolymph sporozoites in *gfp-trp1∆N* and *gfp-trp1∆C*, the ratio of HLS to MGS for *gfp-trp1∆N* was more comparable to that for wild-type parasites, while the ratio in *gfp-trp1∆C* was similar to that in *trp1(-)mCh* ([Figure 4A](#fig4){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}). This suggests that *gfp-trp1∆N* sporozoites are more capable of egressing from oocysts than *gfp-trp1∆C* sporozoites. By contrast, the ratio of SGS to MGS was zero for both *gfp-trp1∆C* and *gfp-trp1∆N*, indicating that the knockout phenotype is only partially restored in *gfp-trp1∆N* parasites. The infectivity of *gfp-trp1comp*, *gfp-trp1*, *gfp-trp1∆C* and *gfp-trp1∆N* was also tested by natural transmission experiments involving mosquito bites ([Table 3](#tbl3){ref-type="table"}, [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). While *gfp-trp1comp* and *gfp-trp1* showed normal infectivity in mice, no infection could be observed for *gfp-trp1∆N* and *gfp-trp1∆C*. These results matched the data for sporozoite numbers in the salivary glands that were zero for both mutants ([Table 2](#tbl2){ref-type="table"}). These data suggest that the N-terminus of TRP1 is important for oocyst egress and that both the N- and the C-terminus are essential for salivary gland invasion. Intriguingly, the N-terminus of TRP1 is the least conserved part of the protein across *Plasmodium* species ([Figure 5A](#fig5){ref-type="fig"}).10.7554/eLife.19157.015Figure 5.TRP1 is post-translationally processed.(**A**) Appearance of conserved residues (identity) and residues with similar charge (similarity) in *Pf*TRP1, *Pv*TRP1 and *Pk*TRP1 in reference to *Pb*TRP1. The graph corresponds to the protein model of TRP1 shown above. The gap marked by a red asterisk indicates an insertion in the sequence that is unique to *Pb*TRP1. Note the less conserved nature of part of the N-terminus. (**B**) Localization of TRP1-GFP, GFP-TRP1comp, GFP-TRP1∆N and GFP-TRP1∆C in oocysts 11--14 days post infection. Nuclear DNA is stained with Hoechst. Scale bar: 10 µm. See also [Video 1](#media1){ref-type="other"}. (**C**) RT-PCR of cDNA generated from midgut sporozoites. Purity of cDNA was tested with α-tubulin I primers amplifying a sequence from exon 2 to exon 3 (left). Splicing of the intron in-between the two exons resulted in a smaller PCR fragment compared to the gDNA. A *gfp:trp1* fusion transcript could be detected in *gfp-trp1comp, gfp-trp1∆N,* and *gfp-trp1∆C* (indicated by red arrowheads) but not in *wt* sporozoites. In addition, two PCRs were performed to detect two different parts of the *trp1* transcript. The gene and protein models shown below and above the images are not drawn to scale. (**D**) Western blot with 100,000 *trp1-gfp* and *csgfp* midgut sporozoites. The two lanes below show as loading control CSP, while the bands above show signals for GFP. Sporozoites expressing TRP1-GFP show a band at \~26 kDa that corresponds to free GFP and a second band at \~35 kDa that corresponds to GFP fused to the C-terminus and the transmembrane domain of TRP1. The predicted size of untagged TRP1 after cleavage of the signal peptide (\~104 kDa) is indicated by a red arrow. Note that the shown images correspond to the same blot that was exposed for the same time. Lanes in-between the shown samples were only removed to simplify the representation.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.015](10.7554/eLife.19157.015)10.7554/eLife.19157.016Figure 5---figure supplement 1.Generation and PCR analysis of parasites expressing TRP1 fused C-terminally to GFP (*trp1-gfp*).Schematic representation of the C-terminal tagging strategy for TRP1. (**A**) The line *trp1-gfp* was generated by transfection of *wt*. The vector contained the positive selection marker *hdhfr*, which was flanked by the C-terminal end of the TRP1 ORF and the TRP1 3'UTR. Integration of this sequence by double crossover homologous recombination resulted in a C-terminal fusion of TRP1 to GFP. Location of primers and approximate length of PCR fragments used for genotyping are indicated by arrows and lines below and above the scheme. (**B**) PCR analysis of clonal *trp1-gfp* and *wt* parasites. The expected sizes of PCR products are indicated below. Note that the PCR for the *trp1-gfp* line of the complete locus (Comp) could not be amplified, presumably because of the length and the high AT content of the sequence.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.016](10.7554/eLife.19157.016)10.7554/eLife.19157.017Table 3.Infectivity of parasite lines to C57/BL6 mice. Data are shown for the TRP1-knockout lines *trp1(-)* and *trp1(-)mCh* as well as for the TRP1 complementations *gfp-trp1comp*, *gfp-trp1∆N* and *gfp-trp1∆C* in comparison to wild-type (*wt -- P. berghei strain ANKA*) and *gfp-trp1*. MG -- midgut; i.v. --- intravenous injection into tail vein.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.017](10.7554/eLife.19157.017)**Parasite lineRoute of inoculationMice positive \#/\#Prepatency*wt***by bite4/43.25***wt***500,000 MG Sporozoites (i.v.)3/46.0***trp1(-)* clone 1**by bite0/4∞***trp1(-)* clone 3**by bite0/4∞***trp1(-)* clone 3**400,000 MG sporozoites (i.v.)2/46.0***trp1(-)mCh***by bite0/4∞***trp1(-)mCh***500,000 MG sporozoites (i.v.)4/46.5***gfp-trp1comp***by bite4/43.0***gfp-trp1***by bite4/43.5***gfp-trp1∆N***by bite0/4∞***gfp-trp1∆C***by bite0/4∞

TRP1 is post-translationally processed {#s2-5}
--------------------------------------

The complemented lines *gfp-trp1comp*, *gfp-trp1∆N* and *gfp-trp1∆C,* as well as the line *gfp-trp1*, were tagged N-terminally with GFP to access the expression and localization of the fusion proteins in vivo. We further constructed a parasite line in which GFP was C-terminally fused to TRP1, termed *trp1-gfp* ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). This line showed no defect in sporozoite egress from oocysts but salivary glands contained consistently less sporozoites compared to wild-type ([Table 2](#tbl2){ref-type="table"}). Interestingly, we could only detect strong GFP fluorescence in the *trp1-gfp* line and weak GFP fluorescence in *gfp-trp1∆N* parasites, while all other lines were non-fluorescent ([Figure 5B](#fig5){ref-type="fig"}). In contrast to *trp1(-)mCh* parasites, which express mCherry early during oocyst formation ([Figure 1A](#fig1){ref-type="fig"}), GFP expression in *gfp-trp1∆N* parasites was only observed in oocysts with already matured sporozoites. This indicates that, beside the transcriptional regulation, TRP1 expression might also be post-transcriptionally regulated by the native 3'UTR, which is not present in *trp1(-)mCh* parasites. To test whether these lines transcribe the *gfp* and *trp1* genes as one transcript, we first performed RT-PCRs with cDNA generated from midgut sporozoites. We were able to amplify a *gfp:trp1* transcript in *gfp-trp1comp*, *gfp-trp1∆N* and *gfp-trp1∆C* sporozoites while no transcript could be detected in *wt*. In addition, we performed two RT-PCRs for *trp1* transcripts, amplifying sequences encoding the TSR and the N-terminus. While the PCR amplifying the TSR sequence gave a product in all lines including *wt*, a product for the N-terminal PCR was only observed in *gfp-trp1comp, gfp-trp1∆C* and *wt* parasites but, as expected, not in *gfp-trp1∆N* parasites ([Figure 5C](#fig5){ref-type="fig"}). Finally, we performed Western blotting, which revealed only a short GFP-fusion protein as well as GFP for the C-terminally tagged full-length TRP1 ([Figure 5D](#fig5){ref-type="fig"}). We could not detect full-length GFP-TRP1, suggesting that the protein is cleaved, and also failed to detect protein for the weakly GFP-expressing N-terminal deletion parasites.

Curiously, the C-terminal GFP-fusion protein of the full-length TRP1 localized strongly at the periphery of the oocyst ([Figure 6A](#fig6){ref-type="fig"}, [Video 1](#media1){ref-type="other"}). By contrast, the GFP-fusion protein of the N-terminally deleted TRP1 did not show this localization and appeared to accumulate only within the sporozoites ([Figure 6B](#fig6){ref-type="fig"}, [Video 1](#media1){ref-type="other"}). Investigation of single sporozoites showed that the C-terminally tagged TRP1 localized at the periphery towards the rear end of the sporozoite, as well as within the sporozoite at the apical end ([Figure 7A](#fig7){ref-type="fig"}, [Video 2](#media2){ref-type="other"}). By contrast, the GFP signal in the *gfp-trp1∆N* sporozoites localized to membranes within the parasite, presumably the endoplasmatic reticulum (ER) as indicated by accumulations around the nucleus ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). A parasite line expressing cytoplasmic GFP was used as a control ([Figure 7C](#fig7){ref-type="fig"}). By using anti-GFP antibodies in fixed sporozoites, we were not able to detect GFP-TRP1∆N on the sporozoite surface ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Comparison of the localizations of TRP1-GFP and GFP-TRAP ([@bib38]) showed that the two proteins were localized differently ([Figure 8](#fig8){ref-type="fig"}). While GFP-TRAP appears mostly localized to micronemes at the front end of the sporozoite, TRP1-GFP appears to localize in what might be a subset of micronemes or a different organelle that does not extend all the way to the front. These data together indicate that TRP1 is transported through the ER, is post-translationally processed and can accumulate at the periphery of the parasite on its rear end.10.7554/eLife.19157.018Figure 6.TRP1-GFP localizes to the oocyst wall while GFP-TRP1ΔN accumulates in the endoplasmatic reticulum (ER).(**A**) Localization of TRP1-GFP in oocysts 11--14 days post infection. Nuclear DNA is stained with Hoechst. The accumulation of GFP at the oocyst wall is indicated by red arrows in the zoomed images. See also [Video 1](#media1){ref-type="other"}. (**B**) Localization of GFP-TRP1∆N at 11--14 days post infection. Nuclear DNA is stained with Hoechst. The dashed white line in the zoomed images indicates the oocyst wall.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.018](10.7554/eLife.19157.018)10.7554/eLife.19157.019Figure 7.TRP1-GFP but not GFP-TRP1[∆]{.ul}N localizes in a polarized fashion at the sporozoite periphery.(**A**) Live imaging of hemolymph sporozoites expressing TRP1-GFP. The line plot below shows the intensity of grey values along the white line indicated in the zoomed image, showing the proximal end of the sporozoite. The GFP signal localizes close to the plasma membrane indicated by the intensity profile showing two peaks on both sides of the sporozoites. The red arrows point to the apical tip of the sporozoites. See also [Video 2](#media2){ref-type="other"}. (**B**) Live imaging of midgut sporozoites expressing GFP-TRP1∆N. The GFP signal is not equally distributed as seen in control parasites in (C) but does not localize close to the plasma membrane as shown in (A). (**C**) Live imaging of a salivary gland sporozoite expressing cytoplasmic GFP. In contrast to (A) and (B), the GFP signal is equally distributed within the cytoplasm.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.019](10.7554/eLife.19157.019)10.7554/eLife.19157.020Figure 7---figure supplement 1.GFP-TRP1∆N does not localize on the sporozoite surface.(**A**) Immunofluorescence of midgut sporozoites against GFP in the presence and absence of Triton-X 100. Note the absence of anti-GFP signal in the unpermeabilized sporozoite, suggesting that the GFP-TRP1∆N fusion protein localizes within the sporozoite and not on the plasma membrane. (**B**) Positive control with antibodies against CSP, visualizing the plasma membrane.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.020](10.7554/eLife.19157.020)10.7554/eLife.19157.021Figure 8.Localization of TRP1-GFP and the micronemal protein TRAP.Comparison of salivary gland sporozoites expressing C-terminally tagged TRP1 (*trp1-gfp*) with salivary gland sporozoites expressing N-terminally tagged TRAP (*gfp-trap*). Zoomed images all show the apical tip of the sporozoites. Three different sporozoites are displayed for each strain. While TRAP shows a micronemal localization, predominantly at the apex of the sporozoite, TRP1 localizes close to the plasma membrane and accumulates at the rear end of the sporozoite.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.021](10.7554/eLife.19157.021)Video 1.Sections in Z-direction through oocysts expressing TRP1-GFP and GFP-TRP1ΔN.Movie showing slices in Z-direction of an oocyst expressing TRP1-GFP (left) and an oocyst expressing GFP-TRP1ΔN (right). Oocysts were imaged with a spinning disc confocal microscope (Nikon Ti series) and a 60x objective (CFI Apo TIRF 60x H; NA 1.49). Only the GFP signal is shown.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.022](10.7554/eLife.19157.022)10.7554/eLife.19157.022Video 2.Salivary gland sporozoites expressing TRP1-GFP gliding.Movie showing salivary gland sporozoites expressing TRP1-GFP gliding close to a salivary gland imaged on a spinning disc confocal microscope (Nikon Ti series) with a 60x objective (CFI Apo TIRF 60x H; NA 1.49). The GFP signal and the differential interference contrast (DIC) are shown beside each other. Note the intra-sporozoite movement of the TRP1-GFP signal, the peripheral localization is mainly at the rear end of the motile sporozoites. Time between frames: 1 s.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.023](10.7554/eLife.19157.023)10.7554/eLife.19157.023

Synchronous activation of mature sporozoites is crucial for effective egress from oocysts {#s2-6}
-----------------------------------------------------------------------------------------

Even if a low number of hemolymph sporozoites could be detected in the *trp1(-)* and *trp1(-)mCh* knockout lines, the presented results indicate that the initial function of TRP1 lies in oocyst egress. To probe this in more detail, we established two new assays to image sporozoite egress from oocysts. These assays imaged extracted midguts placed either on microscope slides and pushed down by a coverslip or in a non-compacted setting in glass-bottom Petri-dishes ([Figure 9A,B](#fig9){ref-type="fig"}). Individual midguts were placed in insect medium (Grace's medium, GibcoTM, Thermo Fisher Scientific, Waltham, MA) and imaged either at high or low magnification for up to one hour. As expected, the frequency of egress events was low for both setups ([Figure 9A,B](#fig9){ref-type="fig"}). However, we were able to observe dozens of egress events. In one type of egress, mostly observed in the slide-coverslip setup, sporozoites were seen to be moving actively inside oocysts followed by egress from oocysts in a manner resembling the merosomes formed by late liver stages ([@bib62]; [@bib6]) ([Figure 9C](#fig9){ref-type="fig"}, [Video 3](#media3){ref-type="other"}). We thus termed these vesicle-like deformations of the cyst wall sporosomes. From a total of over 800 imaged oocysts, we observed active sporozoite motility in 5--6% and egress-like events in about 3% of the wild-type oocysts. The same type of events with similar frequencies were also observed at the 2015 and 2016 *Biology of Parasitism* courses at Woods Hole using mosquitoes from two different insectaries. All egress-like events were preceded by sporozoite motility. By contrast, we observed no egress-like events in the *trp1(-)mCh* line and also no actively moving sporozoites within oocysts ([Figure 9A](#fig9){ref-type="fig"}). Although no egress could be observed in the knockout line, we were concerned that the pressure on the midguts induced by the overlaying cover slip might force sporozoite egress. Therefore, we performed the same assay in glass-bottom Petri-dishes, in which midguts were simply placed in medium with no lid. To this end, we used a fluorescent line (*fluo*) because imaging was performed with low magnification (10x) and egress events were only visible with fluorescence detection. In these experiments, we were able to observe motile sporozoites and their egress in the control at rates similar to those seen in the previous assay. Furthermore, we did not detect motility or egress in the TRP1 knockout ([Figure 9B](#fig9){ref-type="fig"}, [Videos 4](#media4){ref-type="other"}--[6](#media6){ref-type="other"} and [Video 7](#media7){ref-type="other"}). In this assay, we observed a variety of events like rapid bursting of oocysts, sporozoites budding from oocysts and sporozoites moving inside oocysts or their surrounding tissue ([Videos 4](#media4){ref-type="other"}--[6](#media6){ref-type="other"}). In parasites lacking the protease SERA5, we confirmed sporozoite motility within oocysts as described previously ([@bib2]) and did also not witness any egress ([Figure 9A,B](#fig9){ref-type="fig"} and [Videos 7](#media7){ref-type="other"} and [8](#media8){ref-type="other"}). Intriguingly, *sera5(-)* parasites showed about four and eight times more oocysts with motile sporozoites than wild-type oocysts in both assays ([Figure 9A,B](#fig9){ref-type="fig"}), respectively. Considering that *sera5(-)* sporozoites do not exit oocysts, this further suggests that motility precedes egress.10.7554/eLife.19157.024Figure 9.*trp1(-)* sporozoites do not egress from oocysts and do not show intra-oocyst motility.(**A**) Distribution of egress events (dark grey) and oocysts containing motile sporozoites (light grey) in control (*fluo*), wild-type (*wt*) or *sera5(-)* and *trp1(-)mCh* oocysts on a microscope slide covered with a cover slip or (**B**) uncovered in a glass-bottom Petri-dish. As control for a non-egressing strain, a fluorescent (*sera5(-) fluo*) and a non-fluorescent (*sera5(-) non-fluo*) SERA5 knockout line were tested. The different sample preparation methods are depicted below the graphs. Sporozoites budding from oocysts in a sporosome-like manner as well as spontanous bursting of oocysts were classified as egress events ([Videos 4](#media4){ref-type="other"}--[6](#media6){ref-type="other"}). (**C**) Time lapse of a budding event under a cover slip. A wild-type oocyst with budding sporozoites is shown. The start of two budding events is indicated with red arrows. Scale bar: 10 µm. See also [Video 3](#media3){ref-type="other"}. (**D**) Bursting of an oocyst in a glass-bottom Petri-dish. An oocyst expressing GFP bursting and releasing sporozoites is shown. Scale bar: 20 µm. See also [Video 7](#media7){ref-type="other"}.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.024](10.7554/eLife.19157.024)Video 3.Sporozoites are budding from a wild-type oocyst.Movie in differential interference contrast (DIC) of wild-type sporozoites moving inside an oocyst and budding from the oocyst in a sporosome. Imaged on an Axiovert 200M (Zeiss) with a 63x (N.A. 1.3) objective. Time between frames: 30 s. These time-laps series were taken subsequently with \~5--10 s between each series.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.025](10.7554/eLife.19157.025)10.7554/eLife.19157.025Video 4.Oocyst rapidly bursting.Movie showing an oocyst of the *fluo* control line rapidly bursting and disappearing. Fluorescence and differential interference contrast (DIC) are shown beside each other. Imaged on an Axiovert 200M (Zeiss) with a 10x (N.A. 0.5) objective. Time between frames: 30 s.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.026](10.7554/eLife.19157.026)10.7554/eLife.19157.026Video 5.Sporozoites moving inside oocyst.Movie showing *fluo* control sporozoites moving inside an oocyst. Fluorescence and DIC are shown beside each other. Imaged on an Axiovert 200M (Zeiss) with a 10x (N.A. 0.5) objective. Time between frames: 30 s.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.027](10.7554/eLife.19157.027)10.7554/eLife.19157.027Video 6.Sporozoites budding from oocyst.Movie showing *fluo* control sporozoites possibly budding from an oocyst. Fluorescence and DIC are shown beside each other. Imaged on an Axiovert 200M (Zeiss) with a 10x (N.A. 0.5) objective. Time between frames: 30 s.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.028](10.7554/eLife.19157.028)10.7554/eLife.19157.028Video 7.Long-term imaging of mosquito midguts infected with *trp1(-)mCh, sera5(-) fluo* and the fluorescent reporter line *fluo.*Midguts of mosquitoes infected with *trp1(-)mCh, sera5(-) fluo* or a control line were imaged for 1 hr with 30 s per frame. The video shows, consecutively, a midgut infected with *trp1(-)mCh,* a midgut infected with a fluorescent control line and the *sera5(-) fluo* line. Note the absence of any sporozoite movement in the trp1(-)mCh movie, the bursting of an oocysts in the center of the wt control movie, and the intra-oocyst motility of sporozoites in several oocysts in the *sera5(-) fluo* movie. Imaged on an Axiovert 200M (Zeiss) with a 10x (N.A. 0.5) objective. Time between frames: 30 s.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.029](10.7554/eLife.19157.029)10.7554/eLife.19157.029Video 8.*sera5(-) fluo* sporozoites moving inside an oocyst.Movie in differential interference contrast (DIC) showing intra-oocyst motility of *sera5(-) fluo* sporozoites within an oocyst. Imaged on an Axiovert 200M (Zeiss) with a 63x (N.A. 1.3) objective. Time between frames: 1 s.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.030](10.7554/eLife.19157.030)10.7554/eLife.19157.030

Discussion {#s3}
==========

Visualizing sporozoite egress: bursting and budding within vesicle-like structures {#s3-1}
----------------------------------------------------------------------------------

Here, we described for the first time the imaging of *Plasmodium* sporozoite egress from oocysts in situ, which revealed a number of different types of egress events. The most striking was the apparent bursting of sporozoites and the apparent budding of sporozoites within vesicle-like deformations of the cyst wall that we termed sporosomes ([Figure 9C,D](#fig9){ref-type="fig"}; [Videos 3](#media3){ref-type="other"} and [7](#media7){ref-type="other"}). We imaged 547 control oocysts over a total of 16 hr and observed egress events in about 3% of these oocysts, suggesting a rate of 0.5--1 egress events per hour. At this rate, 50% of oocysts in a medium infected midgut (\~100 oocysts) would be emptied in 2--3 days. These numbers suggest that the observed events might well reflect those occurring in vivo. Naturally, in vivo observations would be desirable but intravital imaging in mosquitoes is challenging due to the opaque nature of the chitinous exoskeleton. This can be partially overcome by blood feeding mosquitoes just before imaging; this causes the abdomen to inflate to such a degree that individual oocysts can be imaged by fluorescence microscopy. Yet, it is unclear whether a recent blood meal would influence egress. The application of fiber optic imaging could overcome this challenge ([@bib64]). In this methodology, a thin fiber is introduced into the mosquito and individual oocysts should be visible to the patient observer. However, the low rates of egress events would make imaging egress events in vivo a formidable challenge.

The observation of sporozoite budding into what appears to be membrane-delimited vesicles was both unexpected and curious, as the origin of the surrounding 'membrane' is not obvious. The plasma membrane of the ookinete develops into the plasma membrane of the developing oocyst, which in turn forms the plasma membrane of the sporozoites ([@bib70]; [@bib67]). Hence, sporozoites differ from intracellular growing stages that are surrounded by a parasitophorous vacuole and a host cell plasma membrane: there should be no membrane around the formed sporozoites since they are only surrounded by the oocyst wall. Yet, the appearance of these sporosomes suggests that some form of delimiting 'membrane' is present. Earlier scanning EM images of infected midguts suggested that oocysts can bud off smaller cysts that were called satellites ([@bib61]). It is not clear how satellite formation can occur or how it is initiated, but these observations suggest that the oocyst wall might be not completely rigid and could show some level of elasticity. Hence part of the delimiting 'membrane' of the sporosomes could be derived simply from the oocyst wall and thus not be a lipid membrane but a thin sheet of oocyst wall material, similar to that which might surround sporozoites within satellites. As we only observed sporosome formation at midguts infected with wild-type parasites, it might well be that the oocyst wall is thinned by a succession of parasite-initiated proteolytic events, which are not initiated in *trp1(-)* or *sera5(-)* parasites. These events likely destabilize the wall in a way that enables sporozoites to egress via rupture or budding. Yet, EM imaging of sporulated *trp1(-)mCh* and wild-type oocysts showed no differences in the appearance of the oocyst wall. Even 24 days post infection, *trp1(-)mCh* oocysts showed little difference in morphology and no difference in oocyst wall thickness when compared to wild-type oocysts 12 days post infection ([Figure 10---figure supplement 1](#fig10s1){ref-type="fig"}). These observations could suggest that proteolytic degradation of the oocyst wall is not affected in oocysts lacking TRP1. Alternatively, proteolytic degradation might happen only shortly before or during egress and is therefore hard to observe by electron microscopy in wild-type oocysts. Clearly, in vivo imaging will be needed to confirm whether the different types of egress also occur in living mosquitoes. Nevertheless, our assays will allow a more quantitative description of sporozoite egress from oocysts as already shown in [Figure 9](#fig9){ref-type="fig"} with the comparison between *wt*, *trp1(-)* and *sera5(-)* parasites.

How could TRP1 interact with other proteins to mediate egress? {#s3-2}
--------------------------------------------------------------

What role could TRP1 play during sporozoite egress from oocysts? Many TSR-containing proteins in *Plasmodium* have been studied and shown to have functions in gliding motility. The best example is TRAP, which is believed to interact with actin filaments below the plasma membrane to guide motility possibly by direct force transduction to the substrate. TRAP function is crucial as sporozoites that lack TRAP are not able to perform productive motility ([@bib63]) and are probably, as a consequence, also unable to invade the salivary glands and infect the mammalian host. Other proteins of the TRAP-family were shown to have similar functions. CTRP, for example, fulfills the same role as TRAP but in ookinetes ([@bib19]), and S6/TREP-deficient sporozoites have been shown to be less capable of gliding motility and invasion of salivary glands ([@bib60]; [@bib12]). Interestingly, TRAP-related proteins that lack the penultimate tryptophan in the cytoplasmic tail domain were also shown to support motility. The protein SSP3 is, for example, important for continuous movement of sporozoites ([@bib29]). To accomplish these functions, TRAP-family proteins are localized at the plasma membrane. Therefore, it is likely that TRP1 is also at least partially secreted to the parasite surface, where it could initiate signaling from the outside as has been speculated recently to be the case for sporozoite surface proteins ([@bib36]; [@bib55]; [@bib7]). Indeed surface proteomics of sporozoites ([@bib43]) showed that TRP1, even if just at low amounts, can be detected on the outside of the sporozoite plasma membrane. Once on the surface, TRP1 could lead, for example, to sustained microneme secretion that would maintain or initiate gliding motility. Alternatively, it might play a role in motility by contributing to the disconnection of TRAP from actin filaments at the rear end, where the actin filament binding protein coronin was recently also shown to be localized ([@bib7]). Although these functions remain highly speculative, in the absence of TRP1, there is no motility within oocysts and possibly reduced secretion. A scenario involving TRP1 in signal transduction is not at odds with the observation that isolated *trp1(-)* sporozoites can glide, as other surface proteins can probably also transduce or modulate signals. Also it appears that many diverse ligands can activate sporozoites ([@bib51]). Beside the direct interaction with ligands that make contact with the sporozoite surface, TRP1 could also assist in the correct trafficking and secretion of other proteins, as shown for MIC2 and the MIC2-associated protein ([@bib32]).

Putative pathways that could trigger sporozoite egress from oocysts {#s3-3}
-------------------------------------------------------------------

Clearly, the processes and factors that lead to parasite egress from host cells in general and egress of sporozoites from oocysts in particular are still poorly understood. The factors that are known to date are the serine repeat antigen 5, SERA5 (previously named egress cysteine protease 1; ECP1), the GPI-anchored circumsporozoite protein, CSP ([@bib73]; [@bib2]; [@bib66]), the *Plasmodium* cysteine repeat modular proteins PCRMP3 and PCRMP4 ([@bib22]) and the LCCL-domain-containing proteins PfCCp2 and PfCCp3 ([@bib54]) ([Table 1](#tbl1){ref-type="table"}). Sporozoites lacking SERA5, PCRMP3, PCRMP4, PfCCp2 and PfCCp3 fail to egress from oocysts ([@bib2]; [@bib22]; [@bib54]), whereas parasites lacking CSP do not complete sporozoite formation ([@bib48]). The change of four basic amino acids into alanines within region II+ of CSP allowed normal sporozoite development but blocked egress from oocysts ([@bib73]). All six mutant parasites lines retained their capacity to migrate actively once sporozoites were mechanically released from oocysts ([Table 1](#tbl1){ref-type="table"}). Another protein, the sporozoite invasion associated protein-1 (SIAP-1), possesses no recognizable structural or functional domains but has been identified as having a partial role in sporozoite egress. Parasites that lack SIAP-1 have a strongly reduced rate of sporozoites egressing from oocysts but are still able to enter into salivary glands in low numbers ([@bib24]). In contrast to parasite lines that lack the previously mentioned proteins (SERA5, PCRMP 3 and 4, PfCCp 2 and 3) or parasite lines that contain specific mutations within CSP, SIAP-1 knockout sporozoites also fail to undergo efficient gliding motility ([@bib24]). Similarly, the GPI-anchored micronemal antigen GAMA (previously named PSOP9) has been shown to be essential for egress from oocysts. Sporozoites that lack GAMA are also not able to perform gliding motility in vitro and within oocysts ex vivo ([@bib23]). Interestingly, GAMA is expressed in all *Plasmodium* stages that contain micronemes and has been discussed as a potential vaccine candidate against blood stages ([@bib31]; [@bib5]). This ubiquitous expression profile makes it unlikely that GAMA has a specific function in sporozoite egress from oocysts but suggests that it is important for egress and invasion in general. Therefore the egress defect of *gama(-)* sporozoites presumably causes a defect within the micronemes that has more or less impact dependent on the observed parasite stage. This hypothesis is supported by the observation that *gama(-)* ookinetes produce 78% fewer oocysts than wild-type ookinetes, indicating that the loss of GAMA has an effect prior to oocyst development.

We speculate that two different pathways, involving either intracellular or extracellular signals, might trigger the release of sporozoites from their oocyst. The intracellular pathway might require quorum sensing between the sporozoites of an oocyst that reponds to the presence or absence of a specific factor once sporulation is completed. This signal might be followed by secretion of micronemal and possibly exonemal proteins (e.g. SERA5) that induce both sporozoite motility and degradation of the oocyst wall. While continuous motility as well as inflow of extracellular factors might further enhance protein secretion, the oocyst envelope might become more and more fragile, leading eventually to sporozoite egress. The extracellular pathway might be initiated by the permeabilization of the oocyst wall, either by intracellular factors that are secreted after sporulation or by the breakdown of the oocyst wall that is not longer maintained once sporulation is completed. The inflow of extracellular factors might initiate the secretion process, which leads, as described for the intracellular pathway, to increased motility as well as breakdown of the oocyst wall and finally sporozoite egress. Independent of the pathway that triggers sporozoite egress, degradation of the oocyst wall is probably an interplay of multiple factors that do not lead to a uniform breakdown of the oocyst envelope but create focal weakenings that enable local release of sporozoites or budding of sporosomes ([Figure 10](#fig10){ref-type="fig"}).10.7554/eLife.19157.031Figure 10.Potential model for sporozoite egress from oocysts.Hypothetical model of a cascade of events that lead to sporozoite egress from oocysts. (**A**) Intracellular pathway --- possible quorum sensing between sporozoites leads to secretion of proteins (e.g. GAMA, SERA5, SIAP-1, TRP1) that trigger gliding motility and degradation of the oocyst wall, which is followed by sporozoite egress. (**B**) Extracellular pathway --- expression of factors (e.g. GAMA, TRP1, SIAP-1) leads to permeabilization of the oocyst wall and inflow of extracellular factors. Inflowing factors trigger secretion of proteins that not only activate gliding motility but also degrade the oocyst wall (e.g. SERA5), which is followed by sporozoite egress. Egress of sporozoites can occur in different ways. (I) Single sporozoite egress --- sporozoites migrate through thin holes in the oocyst envelope. (II) Sporosome formation --- many sporozoites stretch the oocyst wall, leading to the formation of sporozoite filled vesicles (sporosomes) that bud from the oocyst. (III) Bursting oocyst --- rapid rupture of the oocyst wall.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.031](10.7554/eLife.19157.031)10.7554/eLife.19157.032Figure 10---figure supplement 1.Electron microscopy of control (*fluo*) and *trp1(-)mCh* oocysts.Full midguts of the respective parasites were fixed 12 or 24 days post infection and processed for electron microscopy. Two focus sections of each oocyst illustrate the integrity of the oocyst wall indicated by red arrowheads. Scale bars are depicted within the images.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.032](10.7554/eLife.19157.032)

The case for SERA5 and CSP appears clearest in this scenario as the lack of the protease (SERA5) has no influence on gliding and neither has the change of the four amino acids in CSP ([@bib73]; [@bib2]). While clearly speculative, this first model of a cascade of possible events linking secretion, motility and proteolysis can be challenged with future work that should aim to identify missing factors and to dissect their functional role and interplay in sporozoites\' egress from oocysts. To this end, a combination of double-knockouts and our imaging assays will constitute crucial tools.

TRP1 is probably trafficked through the ER {#s3-4}
------------------------------------------

Parasites that lack proteins involved in gliding motility (TRAP and CPβ) do not enter into salivary glands ([@bib63]; [@bib26]) and decreased gliding motility (S6/TREP/UOS3, Coronin, CSP and PAT) often goes along with decreased salivary gland invasion ([@bib13]; [@bib38]; [@bib60]; [@bib12]; [@bib7]; [@bib66]; [@bib46]). Hence parasites that lack proteins involved in both egress and motility are also impaired in salivary gland invasion and thus these proteins are essential for life cycle progression at two subsequent steps. In this context, TRP1 plays a unique role as it mediates egress but appears to have no role in gliding. Therefore, we assumed that sporozoites that lack a functional TRP1 would enter into salivary glands. Interestingly, we could detect hemolymph sporozoites in low numbers, especially at later time points in mosquitoes highly infected with *trp1(-)mCh* parasites. We assume that in these mosquitoes, some of the oocysts released sporozoites, probably due to mechanical stress or oocyst wall degradation due to an arrest in oocyst wall formation. The numbers of hemolymph sporozoites were with a few hundred to a few thousand sporozoites, high enough to expect at least a few hundred sporozoites in the salivary glands. However, this was never observed.

Observations similar to those made for the knockout lines *trp1(-)* and *trp1(-)mCh* were also made for the strains *gfp-trp1∆N* and *gfp-trp1∆C. gfp-trp1∆C* parasites tended to resemble the phenotype of both knockout lines, whereas *gfp-trp1∆N* parasites showed almost normal egress from oocysts but were not able to invade the salivary glands. These deficiencies can be explained differentially. The *gfp-trp1∆C* mutant lacks both the cytoplasmic tail domain (CTD) and the putative micronemal targeting signal F/Y/WXXΦ ([@bib20]; [@bib9]), which consists of an aromatic amino acid on position one and an hydrophobic amino acid (Φ) on position four. Micronemal proteins that lack this signal are directly targeted to the plasma membrane and secreted ([@bib20]). However, we are not able to distinguish if this is also true for *gfp-trp1∆C* parasites because we could not observe any GFP expression in this line. Moreover, we cannot exclude the possibility that interactions with other proteins at the CTD are needed for TRP1 to be functional. Curiously, parasites carrying the full-length C-terminally tagged TRP1, albeit processed, showed no defect in their capacity to exit the oocysts, thus suggesting that an C-terminal GFP does not impair this TRP1 function. However, it did not completely complement salivary gland invasion ([Table 2](#tbl2){ref-type="table"}). This suggests that the C-terminus might function differently in oocyst exit and salivary gland entry.

In the *gfp-trp1∆N* mutant, the complete N-terminus of TRP1 is missing, which had a crucial effect on TRP1 function. Although *gfp-trp1∆N* sporozoites could not be detected in the salivary glands and were not transmitted by the bites of infected mosquitoes, this line showed an egress rate that was only slightly decreased compared to wild-type. This suggests that the C-terminal part of the protein is required for sporozoite egress from oocysts, whereas both C- and N-terminus are needed for salivary gland invasion. Interestingly, *gfp-trp1∆N* was the only N-terminally tagged parasite line that was fluorescent, and the GFP-TRP1∆N fusion protein could be visualized in oocysts and free sporozoites ([Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}). The tagged protein localized to membranes within the parasites, especially around the nucleus, which we believe is the location of the endoplasmatic reticulum (ER). This indicates that TRP1 has a signal peptide and enters the secretory pathway similar to micronemal proteins. However, a distinct GFP signal could be observed only in *gfp-trp1∆N* parasites but not in *gfp-trp1∆C*, *gfp-trp1comp* or *gfp-trp1* parasites. Interestingly, all of these lines transcribe a *gfp:trp1* fusion transcript ([Figure 5C](#fig5){ref-type="fig"}), indicating that transcription takes place as predicted. This evidence, together with the observation that the N-terminus of TRP1 clearly varies in size and is less conserved between different *Plasmodium* species ([Figure 5A](#fig5){ref-type="fig"}, [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}) and the fact that we observed only a very small TRP1-GFP fusion protein by western blotting ([Figure 5D](#fig5){ref-type="fig"}), suggests that post-translational processing of TRP1 takes place at the N-terminal end, as shown for MIC5 and M2AP ([@bib11]; [@bib28]), and probably also closer to the transmembrane domain. Therefore GFP might be cleaved off and rapidly degraded in *gfp-trp1∆C*, *gfp-trp1* and *gfp-trp1comp* parasites but not in *gfp-trp1∆N* parasites. Further mutants could be generated to investigate these possibilities and to investigate putative cleavage site(s). The low band detected by western blotting might also suggest that the TSR domain is lost. Whether this loss is functionally required would also constitute an interesting avenue of future research.

In conclusion, by imaging oocyst egress of *Plasmodium* sporozoites at the mosquito midgut wall in situ, we were able to observe a variety of egress events indicating that release of sporozoites from oocysts occurs in different ways. In addition, we identified the TRAP-related protein TRP1 as crucial for sporozoite egress and salivary gland invasion in *Plasmodium berghei*, suggesting hypothetical cascades of events that drive sporozoite egress.

Materials and methods {#s4}
=====================

Bioinformatic analysis {#s4-1}
----------------------

*Plasmodium* sequences were retrieved from PlasmoDB (<http://plasmodb.org/plasmo/>, version 26) and multiple sequence alignments were performed with MUSCLE (<http://www.ebi.ac.uk/Tools/msa/muscle/>). Potential signal peptides and transmembrane domains were predicted using SignalP (<http://www.cbs.dtu.dk/services/SignalP/>), SMART (<http://smart.embl-heidelberg.de/>) and TMHMM (<http://www.cbs.dtu.dk/services/TMHMM-2.0/>). The pI values of cytoplasmic tail domains (CTDs) were calculated with Expasy (<http://web.expasy.org/compute_pi/>).

Depiction of the identity and similarity index was based on a multiple sequence alignment with *Pb*TRP1 (PBANKA_0707900), *Pv*TRP1 (PVX_089230), *Pk*TRP1 (PKNH_1316700) and *Pf*TRP1 (PF3D7_0822700). *Pb*TRP1 was used as reference and all parts of sequences that did not align with *Pb*TRP1 were removed. The identity of amino acids was scored manually by determining the number of conserved amino acids at each position. No consensus was scored as 1, consensus in two sequences was scored as 2 and accordingly 3 or 4 if more sequences showed the same amino acid at the same position. The similarity index was determined by the same method but amino acids were grouped according to chemical properties as acidic (D, E), basic (K, R, H), polar (S, T, N, Q) or hydrophobic (A, V, I, L, M, F, Y, W). The amino acids cysteine, glycine and proline were not grouped and were compared individually. The obtained data was smoothed with the running average of 10 and plotted with GraphPad Prism 5.0 (GraphPad, San Diego, CA, USA).

Generation of parasite lines *trp1(-)*, *trp1(-)*rec and *trp1(-)mCh* {#s4-2}
---------------------------------------------------------------------

*trp1(-)* parasites were generated by amplifying 825 bp upstream of PBANKA_0707900 via PCR with the primers P606 and P607 ([Table 4](#tbl4){ref-type="table"}). The product was used as 5\' UTR for homologous recombination and cloned in front of the positive-negative selection marker *hdhfr-yfcu* in the Pb262 vector ([@bib17]). In a second step, the 3\' UTR (1,040 bp) was amplified with the primers P608 and P609 and cloned in the Pb262-PBANKA0707900-int vector downstream of the selection cassette to enable double crossover homologous recombination via both introduced sequences (5\' and 3\' UTR) and therefore exchange of the *trp1* open reading frame (ORF) with the selection cassette. The final vector Pb262-PBANKA0707900-KO was digested (*SalI* and *XhoI*), purified (High Pure PCR Product Purification Kit, Roche) and transfected into the *P. berghei* strain ANKA using standard protocols ([@bib35]). Subsequently, parasites that integrated the desired DNA fragment were selected by administration of pyrimethamine (0.07 mg/mL) in the drinking water. *trp1(-)* parasites were then cloned to generate isogenic populations and negatively selected using 5-fluorocytosine (1 mg/mL) ([@bib42]) to give rise to *trp1(-)rec* parasites that lost the selection cassette ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). *trp1(-)rec* parasites were cloned and used for complementation approaches with *gfp-*tagged full-length (*gfp-trp1comp*) and N- and C-terminally (*gfp-trp1∆N* and *gfp-trp1∆C*) truncated *trp1* constructs ( [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). The *gfp*-tagged full-length *trp1* construct was also transfected into the *P. berghei* ANKA strain to generate the parasite line *gfp-trp1*, which is genetically identical to *gfp-trp1comp*. In addition to *trp1(-)*, a second knockout line was generated to track promoter activity of *trp1* in vivo as follows. To generate the promoter-reporter construct, the 5\'UTR of *trp1* was amplified with the primers P606 and P887 (858 bp). The construct is based on the Pb262 vector that used the same selection cassette as before but which also contained the *mCherry* gene followed by a *dhfs* terminator. The generated 5\' UTR was cloned via *SalI* and *NdeI* directly in front of the *mCherry* gene to enable transcription in vivo upon *trp1* promoter activation ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The 3\'UTR was amplified and cloned as described above to enable double crossover homologous recombination. The final vector was transfected into the *P. berghei* ANKA strain as described above. Note that the distance between the *trp1* ORF and its neighboring downstream gene (PBANKA_0708000; SEC23) amounts to just 291 bp. To avoid an influence in transcription of PBANKA_0708000 but ensure efficient recombination, we decided to leave a part of the *trp1* coding sequence attached to the 3\' UTR. Therefore, all generated knockout lines described in this study still contain 609 bp of the *trp1* ORF but will be referred to as *trp1* knockout.10.7554/eLife.19157.033Table 4.Primer sequences. Primers used for the generation of the different parasite lines, genotyping and reverse transcriptase (RT-) PCR.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.033](10.7554/eLife.19157.033)**Primer no.Sequence**P99CTAGCTAGCTTAATCATTCTTCTCATATACTTCP232CGCGGATCCTTACTTGTACAGCTCGTCCATGCP234CTTGCACCGGTTTTTATAAAATTTTTATTTATTTATAAGCP583AGTCATGCTGTTTCATGTGATCP600CCCAAGCTTCAAAAAAGCAGGCTTGCCGP601GCCGATATCCAAGAAAGCTGGGTGGTACCCP606GTAGGTCGACTGCTTAAACAGAAATTTCTGAACTTTGTTAGGP607GTAGGAATTCATCATGGTTCAGCTTTCATAAAAATCTATATGGP608GTAGAAGCTTGAGCTAAATAATAATGACACCGATTTAACGAGP609GTAGCTCGAGCATCTACTACTCATAATACACTTAGTGGAAGTACGP610GTAGCCGCGGTGCTTAAACAGAAATTTCTGAACTTTGTTAGGP611GTAGGACATATGTCTTCCACCTCCACCATTATCGTATTTTTTCAAAGTAGGACCAATCCAP612GTAGGGCGCCGGTGGAGGTGGATGGATTGGTCCTACTTTGAAAAAATACGATAATP616GTAGGGATCCCAAAGCTGAAACTGATGAACCCATAGATGP657GGCATTTAAAACTACTATAGGATGTGGGP682CTCAAGGGTTTGATCAAGAAACTGCAGP694TAACCATCAAAACATCTCGATCTTTCGAGP695AATTTCTTTGACAATTAAATAAACAAGATATATCGCTGP698AAATGTAATTTTAGTTCTTGGTCAGATTGGTCAGP699ATTATCGTATTTTTTCAAAGTAGGACCAATCCAP887GAAGAATATAATTCGATACATATGTTTAGACAAAATCP1296GCGGGATCCATGAGTAAAGGAGAAGAACTTTTCP1408CATTTTCAGATGGTGTTTCAGTTTGTACP1409CATATGAACTACATGCGTTAGAAGCP1410GATGATGATGATGATGAAAATAATGACATGP1411CACCATCAAAACGTAATGAAGCTGP1444CAAATGCCTCCTGACCAGGCP1597GTAGCCGCGGGATGGAAGTTCAAATATGTGTAGACTTACCTTATTGP1562GTAGGACATATGTCTTCCACCATCTTTCTTTATGGTATCTGTAATTATATCATTTTCAGP1564GTAGGTCGACCACTTAAATTTAATGATTAAATGGTGTGTACATTTCTACP1565GTAGGATATCCATATACATAATACACTTATAGACACATTTAAATATGP1566GTAGAAGCTTGACATAGTCATCACAATATTCATTATTCATATATCATACP1567GTAGCTCGAGCAATTTTCCCTTTATAATATTCTGTCTCTTTACATTGCP1595GTAAATAAGAATATGCATATACATGGGTGP1596CTGTTATAGTATGGGCCATGTTTCTGP1602CAGAGATCCTGAATACGACCCTAGP1603CTTTCTTCTGAAACATTATCCTGTAAGC

Generation of *sera5(-) fluo* and *sera5(-) non-fluo* {#s4-3}
-----------------------------------------------------

The fluorescent and non-fluorescent *sera5(-)* lines were generated in a similar way as the *trp1(-)* and the *trp1(-)mCh* line. The 5'UTR (1,081 bp) of *sera5* was amplified with the primers P1564 and P1565 and ligated by *SalI* and *EcoRV* in the Pb262 vector. In a next step, the 3'UTR (1,012 bp) of *sera5* was amplified with the primers P1566 and P1567 and ligated by *HindIII* and *XhoI* in the Pb262 vector that contained already the *sera5* 5'UTR. The final vector was digested and purified as described previously. As the designed construct contained no additional fluorescent marker within the integrated sequence, transfection was performed in the fluorescent background line *fluo* and in *wt* to generate a fluorescent and a non-fluorescent *sera5(-)* strain.

Generation of the parasite lines *gfp-trp1comp*, *gfp-trp1, gfp-trp1∆N*, *gfp-trp1∆C* and *trp1-gfp* {#s4-4}
----------------------------------------------------------------------------------------------------

Complementation of TRP1-knockout parasites was achieved with three different constructs encoding either full-length *trp1* or N- and C-terminal truncated mutants ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). We used the Pb238 vector ([@bib17]) as template for all three complementation constructs. The vector contains the positive selection marker human *dhfr* controlled by the *ef1α* promoter and a *dhfr* terminator from *P. berghei*, as well as a *gfp* upstream of the selection cassette. The 5\'UTR, which included the sequence encoding the signal peptide of *trp1* (989 bp), was amplified with the primers P610 and P611 and fused (by *SacII* and *PshAI*) with the *gfp* gene to tag *trp1* N-terminally. In a next step, the 3\'UTR of *trp1* was amplified with the primers P608/P609 and cloned downstream of the selection cassette to enable integration by double crossover homologous recombination. This vector was named Pb238-PBANKA0707900-int. To generate the vector for complementation with full-length *trp1*, the coding sequence beginning after the signal peptide and the 3\'UTR of *trp1* (3,643 bp) were amplified with the primers P612 and P616. The PCR product was subcloned in the pGEM-T-Easy vector (pGEM-TRP1complete) and fully sequenced. Afterwards, the sequence was cloned (using *KasI* and *BamHI*) in the Pb238-PBANKA0707900-int vector downstream of the *gfp* gene to generate the final construct for complementation. To create truncated mutants, the N- and C-terminus in the pGEM-TRP1complete vector was deleted by site-directed mutagenesis with the primers P694/P695 (C-terminus) and P698/P699 (N-terminus). The PCR products were cloned into the Pb238-PBANKA0707900-int vector as described before. To tag TRP1 C-terminally with GFP, the C-terminal end (1,030 bp) of the *trp1* gene was amplified with the primers P1562 and P1597. The Pb238-PBANKA0707900-int vector was digested with *SacII* and *NdeI* to ligate the previously amplified PCR product in front of the *gfp* and to generate a fusion between both genes. All N-terminally tagged constructs were digested (by *SacII* and *XhoI*), purified (High Pure PCR Product Purification Kit, Roche) and transfected into *trp1(-)rec* parasites using standard protocols. The C-terminally tagged construct was digested and purified in the same way but was transfected into *wt* parasites. Subsequently, parasites that integrated the desired DNA fragment were selected via pyrimethamine as described above.

Generation of isogenic parasite lines {#s4-5}
-------------------------------------

Isogenic parasite lines were generated by serial dilution of parasites obtained from transfections (parental population). Using this method, only single blood stages were injected into 6--10 NMRI mice. Infected mice were bled once parasitemia reached 1--2%. The blood of infected mice was collected and parasites were either frozen as stocks or purified to isolate genomic DNA with the Blood and Tissue Kit (Qiagen Ltd) ([@bib40]).

Mosquito infection {#s4-6}
------------------

For mosquito infections, mice were infected by intraperitoneal injection of frozen stocks (150--200 µL). Stocks were either completely injected or split for injection into two mice and parasites allowed to grow for 3--5 days. Infected mice were either directly fed to mosquitoes or bled and used for a fresh blood transfer of 20,000,000 parasites into two naïve mice. Parasites in mice that received infected blood were allowed to grow for further 3--4 days. To determine the number of male gametocytes, a drop of tail blood was placed on a microscope slide and incubated at room temperature for 10--12 min. If 1--2 exflagellation events per counting field (40x magnification) were observed, mice were anesthetized and fed to mosquitoes ([@bib40]).

Analysis of oocyst and sporozoite development {#s4-7}
---------------------------------------------

To observe the development of oocysts, midguts of 20--30 mosquitoes were isolated at day 12 and day 22 post infection. Midguts were dissected in phosphate buffered saline (PBS) and fluorescent oocysts were manually counted using a stereomicroscope (SMZ1000, Nikon). To investigate the percentage of sporulated and unsporulated oocysts, midguts were also imaged at both time points. Dissected midguts were mounted with a drop of PBS on a microscopy slide and covered with a cover slip. Samples were sealed with paraffin and imaged with an Axiovert 200M (Zeiss) fluorescence microscope using a 63x (N.A. 1.3) objective. At each time point, images of 50--180 oocysts were taken and classified into oocysts that were in the process of budding or contained already mature sporozoites and oocysts that were pre-mature and didn't contain any sporozoites. Experiments were performed in triplicate with different mosquito feedings. Sporozoites were isolated from the midguts, hemolymph and salivary glands of infected mosquitos at days 14, 17/18, 20 and 22 post infection. For each time point, midguts and salivary glands from at least 10 mosquitoes were dissected in PBS, crushed to release sporozoites and counted using a Neubauer counting chamber. To isolate hemolymph sporozoites, mosquitoes were cooled on ice and the last segment of the abdomen was cut with a syringe. Prepared mosquitoes were flushed by inserting a long drawn Pasteur pipette into the lateral side of the thorax and injected with RPMI (supplemented with 50,000 units/L penicillin and 50 mg/L streptomycin). The hemolymph was thus drained from the abdomen, collected on a piece of foil and transferred to a plastic reaction tube (Eppendorf). Hemolymph sporozoites were counted as previously described for midgut and salivary gland sporozoites. To image protein localization or the expression of fluorescent markers, infected salivary glands and midguts were dissected in RPMI and mounted on a microscope slide. Samples were sealed with paraffin and imaged with a spinning disc confocal microscope (Nikon Ti series) using a 60x objective (CFI Apo TIRF 60x H; NA 1.49).

Long-term imaging of infected midguts {#s4-8}
-------------------------------------

Oocysts were either imaged on microscope slides or in glass-bottom Petri-dishes (MatTek corporation, USA). For imaging on microscope slides, infected midguts of *trp1(-)mCh* and *wt anka* day 20 to 22 post infection were dissected in Grace\'s medium (Gibco) and mounted on a microscope slide. Samples were covered with a cover slip, sealed with paraffin and screened for sporozoite movement within oocysts and egress events using an Axiovert 200M (Zeiss) fluorescence microscope with 63x magnification. Imaging in glass-bottom Petri-dishes was performed in the same way, but dishes were filled 10--15 min prior to dissection with 200 µL Grace\'s medium to allow adjustment to room temperature. Microscopy was performed with 10x magnification, therefore only the fluorescent knockout *trp1(-)mCh* and a fluorescent control line expressing mCherry under the *CSP* and eGFP under the *ef1α* promoter (*fluo*) were used. Two to three midguts were imaged (1 frame every 30 s for 30 min to 1 hr) per line each day from day 12 to day 19 post infection.

Sporozoite gliding motility assays {#s4-9}
----------------------------------

To perform sporozoite gliding motility assays, the midguts of 20--30 mosquitoes were dissected in 50 µL RPMI, smashed with a pestle and purified with 17% accudenz as described previously ([@bib39]). Afterwards, 100 µL of purified sporozoites were mixed with 100 µL of RPMI containing 6% bovine serum albumin (BSA) (ROTH Ltd) and transferred into a 96-well plate with an optical bottom (Thermo Fisher Scientific, Nunc). Hemolymph sporozoites were isolated as described above and centrifuged for 5 min at 7,000 rpm (Thermo Fisher Scientific, Biofuge primo). The excess of supernatant was discarded, sporozoites were resuspended in 100 µL of RPMI and mixed in a 96-well plate with 100 µL of RPMI containing 6% BSA. Plates were spun for 3 min at 800 rpm (Heraeus Multifuge S1) and directly imaged using an Axiovert 200M (Zeiss) fluorescence microscope. Movies were recorded in differential interference contrast (DIC) with 25x magnification and one frame every 3 s. Analysis of movies was performed with the software ImageJ. Only sporozoites gliding in a circular manner for at least one circle over the time of five minutes were classified as moving. All other motility patterns, such as floating, attached, patch gliding, waving, twitching ([@bib30]), were classified as non-moving.

Infection by mosquito bites and sporozoite injections {#s4-10}
-----------------------------------------------------

To determine the capacity of the generated parasite strains to undergo transmission from vector to host we performed transmission experiments with infected mosquitoes and sporozoite injections. Infected mosquitoes 17 days post infection were separated in the morning in cups of 10 each and starved for 6--8 hr. Four C57Bl/6 mice per experiment were anaesthetized using a mixture of ketamine and xylazine (87.5 mg/kg ketamine and 12.5 mg/kg xylazine). One anaesthetized mouse was put on each cup and mosquitoes were allowed to bite on the ventral side for approximately 20 min. Directly after the feeding or at the latest the next day, mosquitos that had taken a blood meal were dissected to determine sporozoite numbers within midguts. Salivary glands were not dissected because mosquitoes infected with *trp1(-)* or *trp1(-)mCh* never contained salivary gland sporozoites. For sporozoite injections, midgut (MG) sporozoites were dissected from mosquitoes between day 12 to day 16 post infection. Infected midguts were stored in RPMI medium (containing 50,000 units/L penicillin and 50 mg/L streptomycin) and crushed with a pestle to release the sporozoites. Sporozoites were counted in a Neubauer counting chamber and afterwards diluted to the desired concentration per 100 µL (400,000--500,000 MG sporozoites). For each experiment, four C57Bl/6 mice were injected intravenously. Bitten and injected mice were probed for parasitemia from day 3 to day 10 after injection or exposure to mosquitoes. In addition, the survival of mice was monitored for 30 days post infection. The blood smears were stained in Giemsa solution (Merck) and counted using a light microscope (Zeiss) with a counting grid. The time difference between infection and observation of the first parasite within a blood smear was calculated as prepatency.

Immunofluorescence on midgut sporozoites {#s4-11}
----------------------------------------

Infected midguts were dissected in PBS in a plastic reaction tube (Eppendorf). Sporozoites were mechanically released with a pestle and fixed in 4% paraformaldehyde (PFA) solution (diluted in PBS) overnight at 4°C. Samples were washed three times with PBS and sporozoites pelleted by centrifugation for 3 min at 10,000 rpm (Thermo Fisher Scientific, Biofuge primo). Sporozoites were blocked (PBS containing 2% BSA) or blocked and pemeabilized (PBS containing 2% BSA and 0.5% Triton-X-100) over night at 4°C. Processed sporozoites were pelleted by centrifugation for 3 min at 10,000 rpm (ThermoFisher Scientific, Biofuge primo) and the supernatant discarded. Samples were incubated with primary antibody solutions (anti-CSP mAb 3D11 ([@bib77]), 1:5 (cell culture supernatant); rabbit anti-GFP ABfinity, 1:200 diluted) for 1 hr at room temperature (RT) in the dark and subsequently washed three times with PBS. After the last washing step, samples were resuspended in secondary antibody solutions (Cy5 goat anti-mouse, 1:500; AlexaFluor 488 goat anti-rabbit, 1:500 diluted) and again incubated for 1 hr at RT in the dark. Afterwards, samples were washed again three times in PBS, the supernatant discarded and pellets resuspended in 50 µL PBS. Samples were carefully pipetted on microscopy slides and allowed to settle for 10--15 min at RT. Before the solution dried completely, samples were covered with cover slips and 7 µL of mounting medium (ThermoFisher Scientific, ProLong Gold Antifade Reagent). Samples were allowed to set overnight at RT and then kept at 4°C or directly examined with a spinning disc confocal microscope (Nikon Ti series). All images were acquired with 60-fold magnification (CFI Apo TIRF 60x H; NA 1.49).

Electron microscopy {#s4-12}
-------------------

Infected midguts were dissected as described previously and directly fixed in 2% glutaraldehyde and 2% paraformaldehyde diluted in 0.1 M sodium cacodylate buffer at 4°C overnight. Prepared midguts were washed three times for 5 min in 0.1 M sodium cacodylate buffer and postfixed with 1% osmium (in 0.1 M sodium cacodylate buffer) for 60 min at RT. Samples were again washed two times each with 0.1 M sodium cacodylate buffer and ddH~2~O. For better contrast, samples were incubated in 1% uranyl acetate (in ddH~2~O) at 4°C overnight and washed two times for 10 min with ddH~2~O. Prior to imaging, samples were serially dehydrated with acetone and adapted to embedding solution 'Spurr' (23.6% epoxycyclohexylmethyl-3,4epoxycyclohexyl-carboxylate (ERL); 14.2% ERL-4206 plasticizer; 61.3% nonenylsuccinic anhydride; 0.9% dimethylethanolamine). Treated midguts were embedded in a capsule mould using 'Spurr' and incubated overnight at 60°C. Embedded midguts were sectioned the next day and images were acquired on a JEOL JEM-1400 electron microscope at 80 kV using the TempCam F416 (Tietz Video and Image Processing Systems GmBH, Gautig).

Western blot {#s4-13}
------------

To estimate the molecular weight of the expressed TRP1 and to prove the correct C-terminal tagging with GFP, midguts infected with *csgfp* and *trp1-gfp* parasites were dissected in RPMI medium (containing 50,000 units/L penicillin and 50 mg/L streptomycin). Midguts were smashed with a pestle and free midgut sporozoites purified with accudenz ([@bib39]). After purification, 100,000 midgut sporozoites per tube were centrifuged for 10 min at 13,000 rpm (Thermo Fisher Scientific, Biofuge primo). The supernatant was discarded and the pellet was lysed in 30 µL RIPA buffer (50 mM Tris pH 8, 1% NP40, 0.5% sodium dexoycholate, 0.1% SDS, 150 mM NaCl, 2 mM EDTA) for ≥1 hr on ice. Probes were mixed with Laemmli buffer (containing 10% β-mercaptoethanol) and denaturated for 10 min at 95°C, centrifuged for 1 min at 13,000 rpm (Thermo Fisher Scientific, Biofuge primo) and frozen for 5 min at −20°C. Prepared samples were separated on precast 4--15% SDS-PAGE gels (Mini Protein TGX Gels, Bio-Rad) and blotted on nitrocellulose membranes using the Trans-Blot Turbo Transfer System (Bio-Rad). Membranes were subsequently blocked (PBS containing 0.05% Tween20 and 5% milk powder) and incubated for 1 hr with antibodies directed against GFP (mouse monoclonal antibody, clones 7.1 and 13.1, Roche, 1:1,000 diluted) or CSP (anti-CSP mAb 3D11 ([@bib77]), cell culture supernatant 1:50 diluted). Membranes were washed three times (PBS with 0.05% Tween20) and secondary anti-mouse antibodies (NXA931, GE Healthcare) conjugated to horse peroxidase were applied subsequently for 1 hr (1:10,000 dilution). Prior to incubation with antibodies against CSP, which was used as a loading control, blots were treated with mild stripping buffer according to abcam protocols. Signals were detected using SuperSignal West Pico Chemiluminescent Substrate or SuperSignal West Femto Maximum Sensitivity Substrate (Themo Fisher Scientific).

Reverse transcriptase (RT)-PCR {#s4-14}
------------------------------

Total RNA of midgut sporozoites was isolated using the Qiazol reagent according to the manufacturer's protocol (ThemoFisher Scientific). For each strain, 1--2.5 million sporozoites were dissected between day 12 and day 20 post infection and used for RNA isolation. cDNA was prepared from isolated RNA using the First Strand cDNA synthesis kit (ThemoFisher Scientific). Primers used for PCR amplification of *trp1* and *gfp* using Taq polymerase are given in [Table 4](#tbl4){ref-type="table"}.

Ethics statement {#s4-15}
----------------

All animal experiments were performed according to the FELASA and GV-SOLAS standard guidelines. Animal experiments were approved by the responsible German authorities (Regierungspräsidium Karlsruhe, Tierantrag G-283/14; G-134/14). *Plasmodium* parasites were maintained in NMRI mice that were obtained from JANVIER. The prepatency of infected mice as well as parasite growth were determined with C57Bl/6 mice from Charles River Laboratories. All transfections and genetic modifications were done in the *Plasmodium berghei* ANKA background either directly in the wild-type ([@bib72]) or in wild-type derived strains (e.g. *trp1(-)rec*).

Statistical analysis {#s4-16}
--------------------

Statistical analyses were performed using GraphPad Prism 5.0 (GraphPad, San Diego, CA, USA). Data sets were either tested with a one-way ANOVA or a Student's T-test. A value of p\<0.05 was considered significant.

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/501100001659Deutsche Forschungsgemeinschaft SFB 1129 to Friedrich Frischknecht.

-   http://dx.doi.org/10.13039/501100000854Human Frontier Science Program RGY0071/2011 to Friedrich Frischknecht.

-   http://dx.doi.org/10.13039/501100000780European Commission ERC StG 281719 to Friedrich Frischknecht.

We thank Miriam Reinig and Christian Sommerauer for rearing *Anopheles stephensi* mosquitoes, and Stefan Lindner and Samantha Ebersoll for technical assistance. We thank also Ross Douglas and Mirko Singer for helpful comments on the manuscript and Stephanie Gold, as well as Stefan Hillmer at the Heidelberg University Electron Microscope Core Facility (EMCF), for their help with the EM component of the work. A big thank you to the Biology of Parasitism (BoP) courses 2015 and 2016 at the Marine Biological Laboratory in Woods Hole for helpful discussions and experiments on oocyst imaging. This work was funded by grants from the European Research Council (ERC StG 281719), the Human Frontier Science Program (RGY0071/2011) and the German Research Foundation (SFB 1129). FF is a member of the Heidelberg University cluster of Excellence *CellNetworks*. DK is a member of the Hartmut Hoffman-Berling International Graduate School (HBIGS).

Additional information {#s5}
======================

The authors declare that no competing interests exist.

DK, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

FF, Conception and design, Analysis and interpretation of data, Drafting or revising the article.

Animal experimentation: All animal experiments were performed according to the FELASA and GV-SOLAS standard guidelines. Animal experiments were approved by the responsible German authorities (Regierungspräsidium Karlsruhe, Tierantrag G-283/14; G-134/14). For all mosquito feeding procedures mice were anesthetized with a mixture of ketamine and xylazine to minimize suffering.

Additional files {#s6}
================

10.7554/eLife.19157.034

###### Alignment of TRP1 homologues from different *Plasmodium* species.

Multiple sequence alignment with TRP1 homologues from *P. berghei*, *P. chabaudi*, *P. yoelii 17X*, *P.vivax*, *P. knowlesi and P. falciparum 3D7*. Highly conserved residues are written in white and highlighted in black, mostly conserved residues are highlighted in dark grey and less conserved residues are highlighted in light grey. The N-terminus (not present in *gfp-trp1ΔN*) is marked with a green line, the thrombospondin repeat is indicated in blue, the transmembrane domain is marked in orange and the C-terminus (not present in *gfp-trp1ΔC*) is highlighted in yellow. The red line marks a short sequence of 11 amino acids that is duplicated in the tagged lines *gfp-trp1ΔN, gfp-trp1ΔC, gfp-trp1comp* and *gfp-trp1* before and after the *GFP* to ensure the structural integrity of the protein.

**DOI:** [http://dx.doi.org/10.7554/eLife.19157.034](10.7554/eLife.19157.034)

10.7554/eLife.19157.037

Decision letter

Krzych

Urszula

Reviewing editor

Walter Reed Army Institute of Research

,

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Motility precedes egress of malaria parasites from oocysts\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Urszula Krzych as the Reviewing Editor and Richard Losick as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Catherine Braun-Breton (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. As you will see, among other things, we require a more precise demonstration of processing and cell surface localization of the Trp1 protein. It will help to know if you are prepared to perform the essential experiments, and if so, if you will be able to provide such analysis within a reasonable period of time.

Summary:

The authors identified thrombospondin-related protein 1 as being crucial for egress from oocysts that develop in the midgut of *Plasmodium* infected mosquitos. The results are based on the analysis of two different knockouts lines along with extensive characterization of sporozoite development, motility, ability to reach salivary glands, and mouse infectivity. The findings suggest that Trp1 is required for motility within oocysts as a prelude to egress and that sporozoites egress from oocysts by several different styles, including release of free sporozoites from a defined point(s) or release of encased sporozoites as a group. Although for the most part the work is thorough and the experiments well executed, there are substantial concerns expressed by the reviewers and these include additional data, expansion of the Discussion as well as some degree of toning down the importance of some aspects of the findings.

Essential revisions:

1\) The identification of two egress styles is novel, as is the imaging setup to video capture sporozoites egress from oocysts. However, a caution should be exercised about discussing sporosomes as \"structures\" rather than oocyst wall deformations due to a thinned wall pushed by motile sporozoites (like the plasma membrane deformation induced by motile intracellular *Listeria*). The fact that the N-term domain of Trp1 complemented the egress defect but not the salivary gland invasion deficiency is an interesting phenotype. A more precise localization of the wild type and mutant Trp1 proteins would help to explain/speculate on Trp1 biological roles. Such a study may involve immunoEM where your lab or a collaborator may be prepared to examine the cell surface disposition of Trp1.

2\) The part of the Discussion regarding the new egress type should be rewritten to tone-it-down, unless the authors can document the so called sporosomes as clearly defined structures.

3\) There is a lack of convincing evidence that Trp1 is on the sporozoites surface. Showing surface expression would support a model of Trp1 involvement in binding extracellular components or transmitting a signal.

4\) Because only the *trp1* construct lacking the N-terminal domain of Trp1 is detected by GFP fluorescence, the authors propose that Trp1 is N-terminally processed. This might indeed be the case but other possibilities such a different intracellular location might also explain this observation: the fluorescence of GFP might indeed be altered and thus not detected in some intracellular compartments. The processing of Trp1 should thus be further documented by western-blot experiments.

5\) Grater clarification of the sporozoite counts need to be include; the authors should separate midgut sporozoite counts (high numbers) from hemolymph and salivary glands (low numbers) and present for each localization in the different parasite lines.

6\) The authors assume TRP1 traffics through the micronemes, yet no confirmatory data is shown. Could co-stains be performed with a bona-fide microneme protein for reference?

7\) Mutants for SERA5, *ccp2/ccp3, pcrmp3/pcrmp4,* and *psop9* all fail to egress yet show in vitro motility, so this aspect of the *trp1* mutant is not novel. If the authors have one or more of the previously described egress mutants in hand (SERA5, *ccp2/ccp3, pcrmp3/pcrmp4*, and *psop9*) then perhaps they can image them in the new assay to provide additional insight/distinctions.

8\) The observation that motility precedes sporozoite egress requires a confirmatory data by yet another assay.

9\) Please expand your Discussion and comment on other previously identified proteins required for sporozoite egress.

10\) Also, please comment how is this mutant phenotype different from other sporozoite egress mutants that are motile when physically released from the oocyst. Although it may be difficult to provide conclusive answers as the mutants have not been imaged directly in this new assay, this point should at least be added to the Discussion.

10.7554/eLife.19157.038

Author response

*Essential revisions:*

1\) The identification of two egress styles is novel, as is the imaging setup to video capture sporozoites egress from oocysts. However, a caution should be exercised about discussing sporosomes as \"structures\" rather than oocyst wall deformations due to a thinned wall pushed by motile sporozoites (like the plasma membrane deformation induced by motile intracellular Listeria). The fact that the N-term domain of Trp1 complemented the egress defect but not the salivary gland invasion deficiency is an interesting phenotype. A more precise localization of the wild type and mutant Trp1 proteins would help to explain/speculate on Trp1 biological roles. Such a study may involve immunoEM where your lab or a collaborator may be prepared to examine the cell surface disposition of Trp1.

We thank the reviewers for appreciating the key novelties of our paper and their constructive critique. We changed "structures" into "vesicle-like deformations of the cyst wall" (subsection "Synchronous activation of mature sporozoites is crucial for effective egress from oocysts" and subsection "Visualizing sporozoite egress: Bursting and budding within vesicle-like structures", first paragraph), which is indeed a clearer message. In order to investigate the localization of TRP1 more precisely (and also to understand the processing of the protein better -- see below) we generated a new parasite line that expresses a C-terminally GFP-tagged TRP1. Although this did not allow us to investigate directly the surface (the GFP-tag is presumably on the insight of the plasma membrane), we could reveal an intriguing polarized localization to the periphery (likely surface). TRP1 is localized mostly at the rear end of the parasite. Interestingly, another protein with such a clear polarized localization to the rear is the actin filament binding protein coronin (recently published by us in Plos Pathogens). Sporozoites lacking coronin have a problem with gliding motility and salivary gland invasion. As *trp1(-)* sporozoites also fail to enter into salivary glands, these proteins might somehow act in a similar way. We added the new data for TRP1-GFP into [Figures 5](#fig5){ref-type="fig"}--[8](#fig8){ref-type="fig"} and the accompanying text in the Results (subsection "TRP1 is post-translationally processed") and Discussion (subsection "TRP1 is likely trafficked through the ER", second and third paragraphs). As to immuno EM we don't hold the technique to high in esteem for sporozoites for various reasons, mostly because in our view it only has produced nice results for highly expressed proteins (e.g. CSP and TRAP), but TRP1 is clearly not among them. Nevertheless, we tried already early on to raise antibodies against TRP1 but failed in two attempts to get an antibody that was specific enough in Western blotting to be used in either immunofluorescence or EM analysis (see [Author response image 1](#fig11){ref-type="fig"} and [Author response image 2](#fig12){ref-type="fig"}). As the N-terminally tagged GFP is cleaved from the protein, we could not use an anti-GFP antibody to probe surface location as we initially hoped. The questions on where TRP1 is cleaved and by which enzyme clearly requires future research. Our also added data on *sera5(-)* parasites suggest that it is not this protease that processes TRP1 (see below).10.7554/eLife.19157.035Author response image 1.A peptide antibody designed against the TRP1 C- terminus does not recognize TRP1 by immunofluorescence and western blot.(**A**) Immunofluorescence on permeabilized (Triton-X 100) midgut sporozoites of *wt* and *trp1(-)mCh*. The staining with αCSP antibodies, which label the sporozoite surface, was included as control to validate the staining procedure. Note that the immunofluorescence with the C-terminal αTRP1 antibody showed in both strains an equivalent intensity suggesting no specific binding to TRP1. (**B**) Illustration of TRP1, the location and sequence (15 last amino acids) of the peptide used for raising the antibody. (**C**) Western blot with *wt* control and *trp1(-)mCh* midgut sporozoites. The C- terminal αTRP1 antibody recognizes an unknown *Plasmodium* or *Anopheles* protein (lower images). CSP was used as a loading control (upper images).**DOI:** [http://dx.doi.org/10.7554/eLife.19157.035](10.7554/eLife.19157.035)10.7554/eLife.19157.036Author response image 2.A peptide antibody designed against the TRP1 N- terminus does not recognize TRP1 by immunofluorescence and western blot.(**A**) Immunofluorescence on permeabilized (Triton-X 100) midgut sporozoites of *wt* and *trp1(-)mCh*. The staining with αCSP antibodies was included as control to validate the staining procedure. The immunofluorescence signal with the N- terminal αTRP1 was not significantly different from background suggesting non- specific binding. (**B**) Illustration of TRP1, the location and sequence (15 amino acids) of the peptide used for raising the antibody. (**C**) Western blot with *wt* (control) midgut sporozoites. The N-terminal αTRP1 antibody doesn't recognize any *Plasmodium* protein. Note that the unspecific binding between 150 and 250 kDa corresponds to a shading of the membrane but not a distinct band that got enhanced during the scanning of the western blot. CSP was used as a loading control (on the right side). Both images correspond to the same sample on the same western blot.**DOI:** [http://dx.doi.org/10.7554/eLife.19157.036](10.7554/eLife.19157.036)

2\) The part of the Discussion regarding the new egress type should be rewritten to tone-it-down, unless the authors can document the so called sporosomes as clearly defined structures.

We renamed the "structures" into "vesicle-like deformations of the cyst wall" and also added a cautionary sentence that states that in vivoimaging will be needed to test which of the observed events do occur (subsection "Visualizing sporozoite egress: Bursting and budding within vesicle-like structures", last paragraph). We further added cautionary adjectives such as "apparent" (in the first paragraph of the aforementioned subsection) and stated that this observation was "unexpected" (last paragraph) to hopefully clearly state that this observation is not written in stone.

3\) There is a lack of convincing evidence that Trp1 is on the sporozoites surface. Showing surface expression would support a model of Trp1 involvement in binding extracellular components or transmitting a signal.

To address the localization of TRP1 in more detail we generated a new parasite line named *trp1-gfp* that expresses TRP1 fused C-terminally to GFP. Indeed *trp1-gfp* parasites showed a much stronger expression of GFP than all other lines and differed in the localization in oocysts and sporozoites significantly from *gfp-trp1:ΔN* parasites. To show the localization in more detail we included the three new [Figures 6](#fig6){ref-type="fig"}--[8](#fig8){ref-type="fig"}. In sporozoites TRP1-GFP localized in a polarized fashion at the periphery, probably to the plasma membrane. However, we can't tell from the images if TRP1 localizes to the inner membrane complex, within the inner membrane space of at the plasma membrane itself. We are also not able to address this question further, for example by immunofluorescence on unpermeabilized sporozoites, since we did not manage to raise an antibody against TRP1. Nevertheless, we think that the new data, together with recently published proteomics data (Lindner et al., Mol Cell Proteomics 2013) are a strong hint that TRP1 is a surface protein that could be involved in signaling processes. We also compared TRP1-GFP localization with that of GFP-TRAP, which revealed a distinct localization, although the signals partly overlap in the apical part, suggesting that TRP1 might be localized in a subset of micronemes or a different set of secretory vesicles.

4\) Because only the trp1 construct lacking the N-terminal domain of Trp1 is detected by GFP fluorescence, the authors propose that Trp1 is N-terminally processed. This might indeed be the case but other possibilities such a different intracellular location might also explain this observation: the fluorescence of GFP might indeed be altered and thus not detected in some intracellular compartments. The processing of Trp1 should thus be further documented by western-blot experiments.

Thanks for this suggestion. We now included a western blot in [Figure 5](#fig5){ref-type="fig"} showing that the molecular weight of TRP1 is significantly smaller than predicted. This suggests that not only the N-terminus is cleaved but also the TSR. Whether this is due to a single or multiple cleavage events should be addressed in future research.

5\) Grater clarification of the sporozoite counts need to be include; the authors should separate midgut sporozoite counts (high numbers) from hemolymph and salivary glands (low numbers) and present for each localization in the different parasite lines.

Thanks also for these suggestions. We included [Table 2](#tbl2){ref-type="table"} into the paper, where for all experiments the number of counted sporozoites in midguts, hemolymph and salivary glands are listed. Together with the new generated line *trp1-gfp* we added also additional images of oocysts and midgut sporozoites of the parasite line *gfp-trp1ΔN* shown in the new [Figures 5](#fig5){ref-type="fig"}--[8](#fig8){ref-type="fig"}.

6\) The authors assume TRP1 traffics through the micronemes, yet no confirmatory data is shown. Could co-stains be performed with a bona-fide microneme protein for reference?

Having generated a new parasite line expressing C-terminally tagged TRP1, we compared TRP1-GFP localization with that of GFP-TRAP (new [Figure 8](#fig8){ref-type="fig"}). This revealed a distinct localization, although the signals partly overlap in the apical part, suggesting that TRP1 might be localized in a subset of micronemes or a different set of vesicles. Subsets of micronemes have indeed been found in *T. gondii* tachyzoites, which are much larger and hence amenable to super-resolution imaging (Kremer et al., Plos Path 2013). We also applied two different super-resolution imaging techniques on sporozoites with both Prof. Christoph Cremer (GSDM) and Prof. Stefan Hell (STED), but both did not allow us to distinguish between two neighboring micronemes. We currently aim at establishing proximity biotinylation methods for sporozoites, which will ultimately be helpful of biochemically distinguishing such populations. However, currently we only had success with gametocystes (Kehrer et al., Mol Cell Proteom 2016) and ookinetes (unpublished) but with sporozoites we still struggle with the amount of collected protein needed for analysis by mass spectrometry.

*7) Mutants for SERA5, ccp2/ccp3, pcrmp3/pcrmp4, and psop9 all fail to egress yet show* in vitro *motility, so this aspect of the trp1 mutant is not novel. If the authors have one or more of the previously described egress mutants in hand (SERA5, ccp2/ccp3, pcrmp3/pcrmp4, and psop9) then perhaps they can image them in the new assay to provide additional insight/distinctions.*

To address this comment we generated a fluorescent and a non-fluorescent SERA5 knockout line (*sera5(-) fluo* and *sera5(-) non-fluo*). Both lines were tested in the new assays and the generated data were included in [Figure 9](#fig9){ref-type="fig"}. Futhermore the ratio of hemolymph and midgut sporozoites respectively salivary gland and midgut sporozoites were included in [Figure 3](#fig3){ref-type="fig"}. The sporozoite counts for both lines are also shown in [Table 2](#tbl2){ref-type="table"}. Two videos ([Videos 7](#media7){ref-type="other"} and [8](#media8){ref-type="other"}) showing intra-oocyst motility in *sera5(-)* oocysts at different magnifications were added. The [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} was included to illustrate the generation of both SERA5 knockout strains. Considering that we could confirm (Aly and Matuschewski J. Ex. Med. 2005) intra-oocyst motility in *sera5(-)* parasites but did not see any such motility in *trp1(-)* parasites also suggests that SERA5 does not cleave TRP1 as in such a case both phenotypes should be equivalent.

8\) The observation that motility precedes sporozoite egress requires a confirmatory data by yet another assay.

The best such assay would clearly be in vivoimaging, which we discuss at length to be currently not possible. As a "next-best assay", however, we did include one more mutant that has the most striking phenotype of all currently available oocyst egress mutants in our analysis: *sera5(-)* sporozoites were confirmed to be motile in oocysts in both our assays but were not able to exit as previously reported (Aly and Matuschewksi, J. Ex. Med. 2005). Importantly we quantified this effect and found about 4-8 times as many oocysts that show intra-oocyst motility compared with *wt* parasites, depending on the assay used ([Figure 9](#fig9){ref-type="fig"}). This striking finding suggests strongly that movement precedes motility as now stated at the end of the Results section.

9\) Please expand your Discussion and comment on other previously identified proteins required for sporozoite egress.

We expanded the discussion on GAMA (formerly named PSOP-9), which has multiple roles in addition to egress of sporozoites (subsection "Putative pathways that could trigger sporozoite egress from oocysts", first paragraph). We also discuss every single protein revealed to date as being important in sporozoite egress from oocysts in a concise manner but did not expand further from the previous text. Expanding this part would in our view distract from the main flow of the Discussion and decrease readability. We hope that the reviewers will recognize that our paper includes several different transgenic lines and establishes new assay systems that allow (with the inclusion of the *sera5(-)* parasites) a quantitative comparison of sporozoite egress from oocysts for the first time. This leads for the first time to a suggestion of a cascade of events that might mediate sporozoite egress. We thus decided not to expand the discussion on individual proteins even more, especially as we cannot yet come to a final conclusion on the mechanisms at work.

10\) Also, please comment how is this mutant phenotype different from other sporozoite egress mutants that are motile when physically released from the oocyst. Although it may be difficult to provide conclusive answers as the mutants have not been imaged directly in this new assay, this point should at least be added to the Discussion.

We include the statements "However, our assays will allow a more quantitative description of sporozoite egress from oocysts as already shown in [Figure 9](#fig9){ref-type="fig"} with the comparison between *wt, trp1(-)* and *sera5(-)* parasites." and "To this end a combination of double-knock outs and our imaging assays will provide crucial tools" in the Discussion. These were added, as we think that the generation of double mutant lines using the positive-negative selection marker *hdhfr-yfcu* or *crispr/cas9* in combination with our visual assays will ultimately lead the way forward to understand sporozoite egress from oocysts in more detail.

[^1]: \* Previously named ECP1 ([@bib2]).

[^2]: ^†^ Previously named PSOP9 ([@bib23]).

[^3]: ^‡^ Information added during proof ([@bib14]).
